| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 PCDHA9 PCDHB5 FAT2 C1S PCDH18 PITPNM2 NID2 FAT4 PCDHGC5 DSG2 PCDHGA9 PCLO PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 BCAN RET CDH5 PCDHGA8 CDH15 CDH17 | 3.15e-10 | 749 | 210 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | NRG1 ADAM18 ZC3H15 ITGAM NLGN3 FASN PTPRD PTPRF F11R PTPRJ NLGN2 FLNB FN1 DSG2 TNC ICAM1 TNN TNR CDH5 TNXB CDH15 CDH17 | 3.86e-07 | 599 | 210 | 22 | GO:0050839 |
| GeneOntologyMolecularFunction | integrin binding | 2.55e-06 | 175 | 210 | 11 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.14e-05 | 188 | 210 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | RPS3 TUBA3E COL6A5 TUBA8 NEB TUBA3C TUBA1B TUBA1A NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC TUBA3D PCLO TUBA1C SRBD1 TECTA ACTR2 SHANK2 TNXB | 6.79e-05 | 891 | 210 | 23 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 7.10e-05 | 130 | 210 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.94e-04 | 51 | 210 | 5 | GO:0043394 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | RPS3 PPM1J INPP4B CNOT8 ABHD17C FASN PTPRD PTPRF PTPRJ PTPRQ CCR5 EXOSC9 REXO4 GDPD3 PTPRU ABHD17B SLFN13 ALKBH3 SLFN11 TNS1 | 3.50e-04 | 807 | 210 | 20 | GO:0016788 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.99e-04 | 17 | 210 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.99e-04 | 17 | 210 | 3 | GO:0019198 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PCDHA9 PCDHB5 FAT2 PTPRF PKD1 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 1.37e-23 | 187 | 207 | 27 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | NRG1 DCHS2 PCDHA9 PCDHB5 ITGAM FAT2 PTPRD PTPRF PKD1 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 ICAM1 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 6.12e-22 | 313 | 207 | 31 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MAGI1 NRG1 DCHS2 TRAF6 PCDHA9 RPS3 PCDHB5 ITGAM NLGN3 FAT2 PTPRD PTPRF F11R PKD1 CCR5 NLGN2 KIT PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 ICAM1 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 FNDC3A PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET PTPRU ROCK1 PARD3 TNR CDH5 TNXB PCDHGA8 CDH15 CDH17 EPHA7 | 3.46e-17 | 1077 | 207 | 46 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell junction organization | NRG1 PCDHB5 ITGAM ABHD17C CDKL5 NLGN3 PTPRD PTPRF F11R PTPRJ TUBA1A CRB3 NLGN2 LRFN1 FN1 PCDHGC5 DSG2 TNC PCLO PCDHB13 PCDHB8 BCAN ACTR2 CRK SHANK2 ABHD17B ROCK1 TANC1 PARD3 TNR TNS1 CDH5 DCLK1 CDH15 CDH17 EPHA4 EPHA7 | 2.36e-12 | 974 | 207 | 37 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | NRG1 PCDHB5 ITGAM ABHD17C CDKL5 NLGN3 PTPRD PTPRF TUBA1A NLGN2 LRFN1 PCDHGC5 TNC PCLO PCDHB13 PCDHB8 BCAN ACTR2 CRK SHANK2 ABHD17B ROCK1 TANC1 TNR DCLK1 EPHA4 EPHA7 | 1.36e-09 | 685 | 207 | 27 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction assembly | NRG1 PCDHB5 NLGN3 PTPRD F11R PTPRJ CRB3 NLGN2 LRFN1 FN1 PCLO PCDHB13 PCDHB8 CRK SHANK2 ROCK1 PARD3 TNS1 CDH5 DCLK1 CDH15 CDH17 EPHA7 | 1.57e-08 | 569 | 207 | 23 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell morphogenesis | NRG1 ATP7A CDKL5 NLGN3 PTPRD PTPRF F11R PTPRJ TUBA1A PTPRQ CCR5 KIT PLXNA1 SOX6 PLXNA3 FLNB FN1 NTF3 ICAM1 BCAN RET TECTA ACTR2 CRK TNN ROCK1 PARD3 TNR CDH5 DCLK1 CDH15 CDH17 EPHA4 EPHA7 | 3.44e-08 | 1194 | 207 | 34 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | ABHD17C CDKL5 NLGN3 PTPRD PTPRF LRFN1 ACTR2 SHANK2 ABHD17B TANC1 DCLK1 EPHA4 EPHA7 | 4.91e-08 | 185 | 207 | 13 | GO:0099175 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | NRG1 CDKL5 NLGN3 PTPRD PTPRF RNF10 CCR5 NLGN2 KIT NOS1 PLXNA1 PLXNA3 FN1 FXR2 NTF3 BCAN TERT ACTR2 APPL2 PARD3 TNR EPHA4 EPHA7 | 8.66e-08 | 625 | 207 | 23 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | NRG1 CDKL5 PTPRD PTPRF RNF10 CCR5 KIT NOS1 PLXNA1 PLXNA3 FN1 FXR2 NTF3 BCAN TERT ACTR2 APPL2 TNR EPHA4 EPHA7 | 2.72e-07 | 515 | 207 | 20 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | NRG1 ABHD17C CDKL5 NLGN3 PTPRD PTPRF TUBA1A NLGN2 LRFN1 ACTR2 SHANK2 ABHD17B ROCK1 TANC1 DCLK1 EPHA4 EPHA7 | 4.09e-07 | 387 | 207 | 17 | GO:0050807 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | NRG1 ABHD17C CDKL5 NLGN3 PTPRD PTPRF TUBA1A NLGN2 LRFN1 ACTR2 SHANK2 ABHD17B ROCK1 TANC1 DCLK1 EPHA4 EPHA7 | 5.44e-07 | 395 | 207 | 17 | GO:0050803 |
| GeneOntologyBiologicalProcess | postsynapse organization | ABHD17C CDKL5 NLGN3 PTPRD PTPRF NLGN2 LRFN1 ACTR2 CRK SHANK2 ABHD17B TANC1 DCLK1 EPHA4 EPHA7 | 6.79e-07 | 313 | 207 | 15 | GO:0099173 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 9.66e-07 | 53 | 207 | 7 | GO:0016339 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | NRG1 ATP7A ATR RPS3 CDKL5 NLGN3 PTPRD PTPRF PTPRJ CRB3 C4A C4B NLGN2 KIT TASOR PLXNA1 PLXNA3 FN1 NTF3 ICAM1 TOM1 ICE1 RET ACTR2 APPL2 TNN ROCK1 PRKCE PARD3 CDH5 TNXB CDH17 EPHA4 | 2.30e-06 | 1366 | 207 | 33 | GO:0051130 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | CDKL5 NLGN3 CCR5 PLXNA1 PLXNA3 FN1 TNC BCAN SLC12A2 TNN TNR DCLK1 EPHA7 | 1.10e-05 | 299 | 207 | 13 | GO:0060560 |
| GeneOntologyBiologicalProcess | regulation of cell development | NRG1 TRAF6 ITGAM INPP4B CDKL5 PTPRD PTPRF F11R RNF10 CCR5 KIT NOS1 PLXNA1 PLXNA3 FN1 FXR2 NTF3 BCAN RET TERT ACTR2 APPL2 ROCK1 TNR CDH5 EPHA4 EPHA7 | 1.48e-05 | 1095 | 207 | 27 | GO:0060284 |
| GeneOntologyBiologicalProcess | synapse assembly | NRG1 PCDHB5 NLGN3 PTPRD NLGN2 LRFN1 PCLO PCDHB13 PCDHB8 CRK SHANK2 DCLK1 EPHA7 | 1.50e-05 | 308 | 207 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.63e-05 | 16 | 207 | 4 | GO:0007158 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | MAGI1 NRG1 TRAF6 RPS3 F11R PTPRJ PKD1 CCR5 PLXNA1 PLXNA3 FN1 TNC ICAM1 AGR2 RET PTPRU CRK TNN ROCK1 PRKCE TNR TNXB EPHA4 EPHA7 | 2.11e-05 | 927 | 207 | 24 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | NRG1 CDKL5 NLGN3 PTPRD PTPRF NLGN2 KIT PLXNA1 PLXNA3 FN1 FXR2 NTF3 BCAN ACTR2 EPHA4 | 2.26e-05 | 418 | 207 | 15 | GO:0051962 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | NRG1 ATP7A ATR RPS3 NLGN3 PTPRD PTPRJ CRB3 NLGN2 KIT TASOR ICAM1 ICE1 ACTR2 ROCK1 PRKCE CDH5 CDH17 | 2.51e-05 | 582 | 207 | 18 | GO:0044089 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 3.38e-05 | 7 | 207 | 3 | GO:0007185 | |
| GeneOntologyBiologicalProcess | neuron projection development | NRG1 ATP7A CDKL5 NLGN3 PTPRD PTPRF TUBA1A CCR5 NLGN2 HERC1 PLXNA1 PLXNA3 FAT4 FN1 TNC NTF3 BCAN RET TECTA ACTR2 CRK TNN ROCK1 PARD3 TNR TNXB DCLK1 EPHA4 EPHA7 | 3.59e-05 | 1285 | 207 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 4.23e-05 | 247 | 207 | 11 | GO:0009612 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 4.80e-05 | 207 | 207 | 10 | GO:1990138 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | NRG1 TRAF6 ITGAM CDKL5 PTPRD PTPRF F11R KIT PLXNA1 PLXNA3 FN1 FXR2 NTF3 BCAN RET ACTR2 CDH5 EPHA4 | 5.04e-05 | 614 | 207 | 18 | GO:0010720 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | CDKL5 PTPRD PTPRF F11R KIT PLXNA1 PLXNA3 FN1 ICAM1 ACTR2 CRK EPHA4 | 5.76e-05 | 302 | 207 | 12 | GO:0022604 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ATP7A CDKL5 NLGN3 PTPRD PTPRF TUBA1A CCR5 PLXNA1 PLXNA3 FN1 NTF3 BCAN RET ACTR2 TNN ROCK1 PARD3 TNR DCLK1 EPHA4 EPHA7 | 6.07e-05 | 802 | 207 | 21 | GO:0048812 |
| GeneOntologyBiologicalProcess | locomotory exploration behavior | 6.26e-05 | 22 | 207 | 4 | GO:0035641 | |
| GeneOntologyBiologicalProcess | cell growth | NRG1 CDKL5 NLGN3 PTPRJ CCR5 PLXNA1 IL17RB PLXNA3 EXOSC9 FN1 TNC CDKN2AIP BCAN CRK TNN TNR DCLK1 EPHA7 | 6.33e-05 | 625 | 207 | 18 | GO:0016049 |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | NRG1 CDKL5 PTPRD PTPRF KIT PLXNA1 PLXNA3 FN1 FXR2 NTF3 BCAN ACTR2 EPHA4 | 6.34e-05 | 354 | 207 | 13 | GO:0050769 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ATP7A CDKL5 NLGN3 PTPRD PTPRF PTPRQ CCR5 PLXNA1 PLXNA3 FN1 NTF3 RET TECTA ACTR2 TNN PARD3 TNR DCLK1 EPHA4 EPHA7 | 6.88e-05 | 748 | 207 | 20 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | ITGAM FAT2 PTPRJ PKD1 NID2 FN1 AGR2 BCAN TECTA CRK TNN ROCK1 PRKCE TNXB | 7.25e-05 | 410 | 207 | 14 | GO:0031589 |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 7.66e-05 | 44 | 207 | 5 | GO:0098698 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 7.91e-05 | 71 | 207 | 6 | GO:0099084 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | MAGI1 NRG1 TRAF6 RPS3 F11R PTPRJ CCR5 FN1 ICAM1 AGR2 RET PTPRU CRK ROCK1 PRKCE TNXB EPHA4 | 8.04e-05 | 579 | 207 | 17 | GO:0045785 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ATP7A CDKL5 NLGN3 PTPRD PTPRF TUBA1A CCR5 PLXNA1 PLXNA3 FN1 NTF3 BCAN RET ACTR2 TNN ROCK1 PARD3 TNR DCLK1 EPHA4 EPHA7 | 8.16e-05 | 819 | 207 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ATP7A CDKL5 NLGN3 PTPRD PTPRF TUBA1A CCR5 PLXNA1 PLXNA3 FN1 NTF3 BCAN RET ACTR2 TNN ROCK1 PARD3 TNR DCLK1 EPHA4 EPHA7 | 9.20e-05 | 826 | 207 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 1.00e-04 | 2 | 207 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.13e-04 | 10 | 207 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | exploration behavior | 1.42e-04 | 50 | 207 | 5 | GO:0035640 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.44e-04 | 192 | 207 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | neuron development | NRG1 ATP7A CDKL5 NLGN3 PTPRD PTPRF TUBA1A PTPRQ CCR5 NLGN2 HERC1 PLXNA1 PLXNA3 FAT4 FN1 TNC NTF3 BCAN RET TECTA ACTR2 CRK TNN ROCK1 PARD3 TNR TNXB DCLK1 EPHA4 EPHA7 | 1.47e-04 | 1463 | 207 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 1.99e-04 | 246 | 207 | 10 | GO:0045216 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 2.43e-04 | 301 | 207 | 11 | GO:0048588 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 2.65e-04 | 13 | 207 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system process | 2.66e-04 | 57 | 207 | 5 | GO:0031646 | |
| GeneOntologyBiologicalProcess | axon development | NRG1 CDKL5 NLGN3 PTPRF CCR5 PLXNA1 PLXNA3 FN1 TNC NTF3 RET TNN PARD3 TNR DCLK1 EPHA4 EPHA7 | 2.74e-04 | 642 | 207 | 17 | GO:0061564 |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 2.89e-04 | 58 | 207 | 5 | GO:0061028 | |
| GeneOntologyBiologicalProcess | neuron apoptotic process | ATP7A GBE1 PTPRF TUBA1A NOS1 COL6A3 PCDHGC5 NTF3 TERT ROCK1 CTSB EPHA4 EPHA7 | 2.90e-04 | 413 | 207 | 13 | GO:0051402 |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 2.99e-04 | 3 | 207 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | NRG1 NLGN3 PTPRD F11R PTPRJ CRB3 NLGN2 LRFN1 ROCK1 DCLK1 EPHA7 | 3.04e-04 | 309 | 207 | 11 | GO:1901888 |
| GeneOntologyBiologicalProcess | presynapse assembly | 3.38e-04 | 60 | 207 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | synaptic signaling | NRG1 PCDHB5 CDKL5 NLGN3 PTPRD RNF10 GNA15 NLGN2 KIT NOS1 FXR2 NTF3 PCLO PCDHB13 PCDHB8 SHANK2 SLC12A2 SV2C PRKCE TNR EPHA4 EPHA7 | 3.42e-04 | 976 | 207 | 22 | GO:0099536 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 3.51e-04 | 93 | 207 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | NRG1 ATP7A CDKL5 NLGN3 PTPRD PTPRF CCR5 KIT PLXNA1 PLXNA3 FN1 ICAM1 RET ACTR2 CRK ABHD17B TNN TNR EPHA4 EPHA7 | 3.51e-04 | 846 | 207 | 20 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 3.58e-04 | 217 | 207 | 9 | GO:1903034 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | ATP7A NEB CDKL5 CCR5 PLXNA3 FN1 PCLO ICAM1 RET SLC12A2 PRKCE TNR EPHA7 | 3.90e-04 | 426 | 207 | 13 | GO:0032535 |
| GeneOntologyBiologicalProcess | T cell extravasation | 4.15e-04 | 15 | 207 | 3 | GO:0072683 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 4.18e-04 | 270 | 207 | 10 | GO:0007160 | |
| GeneOntologyBiologicalProcess | axon extension | 4.34e-04 | 135 | 207 | 7 | GO:0048675 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | NRG1 ATP7A CDKL5 NLGN3 PTPRD PTPRF CCR5 KIT PLXNA1 PLXNA3 FN1 ICAM1 RET ACTR2 CRK ABHD17B TNN TNR EPHA4 EPHA7 | 4.52e-04 | 863 | 207 | 20 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cell size | 4.66e-04 | 225 | 207 | 9 | GO:0008361 | |
| GeneOntologyBiologicalProcess | gliogenesis | NRG1 ITGAM NLGN3 PTPRJ TUBA1A RNF10 SOX6 FN1 NTF3 BCAN TERT PARD3 EPHA4 | 4.75e-04 | 435 | 207 | 13 | GO:0042063 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | NRG1 CDKL5 NLGN3 PTPRD PTPRF CCR5 PLXNA1 PLXNA3 FN1 RET ACTR2 CRK TNN TNR EPHA4 EPHA7 | 4.76e-04 | 612 | 207 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | ATP7A NEB CDKL5 KCNA5 CCR5 NOS1 PLXNA3 FN1 PCLO ICAM1 RET SLC12A2 ROCK1 PRKCE TNR EPHA7 | 5.29e-04 | 618 | 207 | 16 | GO:0090066 |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 5.57e-04 | 38 | 207 | 4 | GO:1902473 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 5.65e-04 | 67 | 207 | 5 | GO:0050775 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 5.93e-04 | 4 | 207 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-matrix adhesion | 5.93e-04 | 4 | 207 | 2 | GO:0007161 | |
| GeneOntologyBiologicalProcess | negative regulation of iron ion transmembrane transport | 5.93e-04 | 4 | 207 | 2 | GO:0034760 | |
| GeneOntologyBiologicalProcess | establishment of endothelial intestinal barrier | 6.11e-04 | 17 | 207 | 3 | GO:0090557 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 6.47e-04 | 69 | 207 | 5 | GO:0010770 | |
| GeneOntologyBiologicalProcess | axon regeneration | 6.47e-04 | 69 | 207 | 5 | GO:0031103 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 6.79e-04 | 40 | 207 | 4 | GO:0048679 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 6.92e-04 | 70 | 207 | 5 | GO:0060999 | |
| GeneOntologyBiologicalProcess | tRNA decay | 7.27e-04 | 18 | 207 | 3 | GO:0016078 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 7.51e-04 | 148 | 207 | 7 | GO:1902414 | |
| GeneOntologyBiologicalProcess | presynapse organization | 8.38e-04 | 73 | 207 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | pyramidal neuron differentiation | 8.57e-04 | 19 | 207 | 3 | GO:0021859 | |
| GeneOntologyBiologicalProcess | glial cell fate commitment | 8.57e-04 | 19 | 207 | 3 | GO:0021781 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | NRG1 ATP7A ATR RPS3 CDKL5 NLGN3 PTPRD F11R PTPRJ CRB3 NLGN2 KIT TASOR LRFN1 ICAM1 ICE1 ACTR2 VPS41 ROCK1 PRKCE CDH5 DCLK1 CDH17 EPHA7 | 8.86e-04 | 1189 | 207 | 24 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 8.95e-04 | 43 | 207 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 8.98e-04 | 198 | 207 | 8 | GO:0048813 | |
| GeneOntologyBiologicalProcess | cell recognition | 8.98e-04 | 198 | 207 | 8 | GO:0008037 | |
| GeneOntologyBiologicalProcess | apical constriction | 9.83e-04 | 5 | 207 | 2 | GO:0003383 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 9.83e-04 | 5 | 207 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 9.83e-04 | 5 | 207 | 2 | GO:1902816 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 1.00e-03 | 20 | 207 | 3 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 1.00e-03 | 20 | 207 | 3 | GO:1903140 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 1.08e-03 | 115 | 207 | 6 | GO:0097061 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CDKL5 NLGN3 PTPRD NLGN2 KIT NOS1 FXR2 NTF3 PCLO SHANK2 SLC12A2 SV2C PRKCE TNR EPHA4 EPHA7 | 1.11e-03 | 663 | 207 | 16 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CDKL5 NLGN3 PTPRD NLGN2 KIT NOS1 FXR2 NTF3 PCLO SHANK2 SLC12A2 SV2C PRKCE TNR EPHA4 EPHA7 | 1.13e-03 | 664 | 207 | 16 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of cell shape | 1.14e-03 | 159 | 207 | 7 | GO:0008360 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection regeneration | 1.25e-03 | 47 | 207 | 4 | GO:0070570 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 1.27e-03 | 80 | 207 | 5 | GO:0001885 | |
| GeneOntologyCellularComponent | tenascin complex | 9.71e-09 | 4 | 209 | 4 | GO:0090733 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | NRG1 ATP7A RPS3 ABHD17C CDKL5 NLGN3 PTPRD PTPRF RNF10 PLEKHA5 NLGN2 NOS1 LRFN1 PCLO SHANK2 ABHD17B TANC1 TNR DCLK1 EPHA4 EPHA7 | 7.26e-08 | 523 | 209 | 21 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic specialization | NRG1 ATP7A RPS3 ABHD17C CDKL5 NLGN3 PTPRF RNF10 PLEKHA5 NLGN2 NOS1 LRFN1 PCLO SHANK2 ABHD17B TANC1 DCLK1 EPHA4 EPHA7 | 7.90e-07 | 503 | 209 | 19 | GO:0099572 |
| GeneOntologyCellularComponent | asymmetric synapse | NRG1 ATP7A RPS3 ABHD17C CDKL5 NLGN3 PTPRF RNF10 PLEKHA5 NOS1 LRFN1 PCLO SHANK2 ABHD17B TANC1 DCLK1 EPHA4 EPHA7 | 1.58e-06 | 477 | 209 | 18 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic density | NRG1 ATP7A RPS3 ABHD17C CDKL5 PTPRF RNF10 PLEKHA5 NOS1 LRFN1 PCLO SHANK2 ABHD17B TANC1 DCLK1 EPHA4 EPHA7 | 3.16e-06 | 451 | 209 | 17 | GO:0014069 |
| GeneOntologyCellularComponent | neuromuscular junction | 1.71e-05 | 112 | 209 | 8 | GO:0031594 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.09e-05 | 17 | 209 | 4 | GO:0098637 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | NRG1 ABHD17C NLGN3 PTPRF RNF10 NLGN2 LRFN1 ABHD17B EPHA4 EPHA7 | 3.63e-05 | 201 | 209 | 10 | GO:0099634 |
| GeneOntologyCellularComponent | anchoring junction | MAGI1 DCHS2 RPS3 PCDHB5 FAT2 KCNA5 F11R PTPRJ CRB3 KIT FLNB FLNC DSG2 TNC ICAM1 PCDHA12 PTPRU ACTR2 PARD3 TNS1 CDH5 CDH15 CDH17 EPHA4 | 4.55e-05 | 976 | 209 | 24 | GO:0070161 |
| GeneOntologyCellularComponent | glutamatergic synapse | NRG1 TRAF6 ABHD17C CDKL5 NLGN3 PTPRD RNF10 PLEKHA5 NOS1 PLXNA1 FXR2 PCLO BCAN SHANK2 ABHD17B PRKCE TANC1 TNR DCLK1 EPHA4 EPHA7 | 7.51e-05 | 817 | 209 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | NRG1 ATP7A ATR RPS3 ABHD17C CDKL5 NLGN3 PTPRF RNF10 PLEKHA5 NLGN2 NOS1 LRFN1 FXR2 PCLO PCDHB13 PCDHB8 ACTR2 SHANK2 ABHD17B TANC1 DCLK1 EPHA4 EPHA7 | 8.75e-05 | 1018 | 209 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | cell-cell junction | MAGI1 DCHS2 PCDHB5 FAT2 KCNA5 F11R PTPRJ CRB3 KIT DSG2 PCDHA12 PTPRU PARD3 CDH5 CDH15 CDH17 EPHA4 | 9.88e-05 | 591 | 209 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | cell surface | ITGAM NLGN3 KCNA5 PTPRJ PKD1 CCR5 NLGN2 KIT IL17RB NID2 LRFN1 DSG2 ICAM1 MUC16 BCAN ACKR4 TNN IL21R CORIN CTSB TNR TNS1 CDH5 CDH17 EPHA4 | 1.29e-04 | 1111 | 209 | 25 | GO:0009986 |
| GeneOntologyCellularComponent | dendrite | ATP7A RPS3 KCNB2 ABHD17C CDKL5 NLGN3 C4A C4B NLGN2 NOS1 FXR2 NTF3 PCLO BCAN RET SHANK2 ABHD17B TNN TANC1 EPHA4 EPHA7 | 1.48e-04 | 858 | 209 | 21 | GO:0030425 |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.53e-04 | 11 | 209 | 3 | GO:0098966 | |
| GeneOntologyCellularComponent | dendritic tree | ATP7A RPS3 KCNB2 ABHD17C CDKL5 NLGN3 C4A C4B NLGN2 NOS1 FXR2 NTF3 PCLO BCAN RET SHANK2 ABHD17B TNN TANC1 EPHA4 EPHA7 | 1.53e-04 | 860 | 209 | 21 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.87e-04 | 157 | 209 | 8 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic membrane | NRG1 ABHD17C NLGN3 PTPRF RNF10 NLGN2 LRFN1 PCDHB13 PCDHB8 SHANK2 ABHD17B EPHA4 EPHA7 | 2.32e-04 | 405 | 209 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.62e-04 | 13 | 209 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 2.96e-04 | 3 | 209 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.08e-04 | 59 | 209 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ATP7A RPS3 KCNB2 ABHD17C CDKL5 NLGN3 PTPRF C4A C4B NLGN2 NOS1 FLNB FXR2 NTF3 PCLO BCAN RET SHANK2 SLC12A2 ABHD17B TNN TANC1 PARD3 EPHA4 EPHA7 | 5.80e-04 | 1228 | 209 | 25 | GO:0036477 |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 5.89e-04 | 4 | 209 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | Hrd1p ubiquitin ligase complex | 5.89e-04 | 4 | 209 | 2 | GO:0000836 | |
| GeneOntologyCellularComponent | synaptic membrane | NRG1 ABHD17C NLGN3 PTPRD PTPRF RNF10 NLGN2 LRFN1 PCDHB13 PCDHB8 BCAN SHANK2 ABHD17B EPHA4 EPHA7 | 8.10e-04 | 583 | 209 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL6A5 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC ICAM1 BCAN TNN CTSB TNR TNXB | 9.39e-04 | 530 | 209 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | ER ubiquitin ligase complex | 9.75e-04 | 5 | 209 | 2 | GO:0000835 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.27e-03 | 230 | 209 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | extracellular matrix | COL6A5 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC ICAM1 BCAN TECTA TNN CTSB TNR TNXB | 2.57e-03 | 656 | 209 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.58e-03 | 137 | 209 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | external encapsulating structure | COL6A5 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC ICAM1 BCAN TECTA TNN CTSB TNR TNXB | 2.64e-03 | 658 | 209 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | symbiont cell surface | 2.68e-03 | 8 | 209 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 3.42e-03 | 9 | 209 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | inhibitory synapse | 3.60e-03 | 31 | 209 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | membrane raft | 3.62e-03 | 362 | 209 | 10 | GO:0045121 | |
| GeneOntologyCellularComponent | axon | NRG1 ATP7A CDKL5 PTPRF C4A C4B NLGN2 NOS1 NTF3 PCLO BCAN RET SHANK2 TNN TANC1 PARD3 DCLK1 EPHA4 | 3.75e-03 | 891 | 209 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | membrane microdomain | 3.76e-03 | 364 | 209 | 10 | GO:0098857 | |
| GeneOntologyCellularComponent | apical plasma membrane | NRG1 ATP7A KCNA5 NPC1L1 PTPRQ CRB3 FN1 DSG2 SHANK2 SLC12A2 PARD3 CTSB | 3.77e-03 | 487 | 209 | 12 | GO:0016324 |
| GeneOntologyCellularComponent | catenin complex | 3.95e-03 | 32 | 209 | 3 | GO:0016342 | |
| Domain | Cadherin | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 5.30e-26 | 113 | 202 | 25 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 6.72e-26 | 114 | 202 | 25 | PS50268 |
| Domain | - | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 6.72e-26 | 114 | 202 | 25 | 2.60.40.60 |
| Domain | CA | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 8.51e-26 | 115 | 202 | 25 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 1.07e-25 | 116 | 202 | 25 | IPR015919 |
| Domain | Cadherin | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET CDH5 PCDHGA8 CDH15 CDH17 | 1.70e-25 | 118 | 202 | 25 | IPR002126 |
| Domain | Cadherin_CS | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CDH5 PCDHGA8 CDH15 CDH17 | 6.06e-25 | 109 | 202 | 24 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 PCDHA9 PCDHB5 FAT2 PCDH18 FAT4 PCDHGC5 DSG2 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CDH5 PCDHGA8 CDH15 CDH17 | 1.54e-24 | 113 | 202 | 24 | PS00232 |
| Domain | Cadherin_2 | PCDHA9 PCDHB5 PCDH18 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 2.27e-19 | 65 | 202 | 17 | PF08266 |
| Domain | Cadherin_N | PCDHA9 PCDHB5 PCDH18 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 2.27e-19 | 65 | 202 | 17 | IPR013164 |
| Domain | Cadherin_tail | PCDHA9 PCDHGC5 PCDHGA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 5.33e-17 | 37 | 202 | 13 | PF15974 |
| Domain | Cadherin_CBD | PCDHA9 PCDHGC5 PCDHGA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 5.33e-17 | 37 | 202 | 13 | IPR031904 |
| Domain | FN3 | PTPRD PTPRF PTPRJ COL6A3 FLNC COL7A1 LRFN1 COL12A1 FN1 TNC FNDC3A PTPRU TNN IL21R TNR TNXB EPHA4 EPHA7 | 1.69e-12 | 185 | 202 | 18 | SM00060 |
| Domain | FN3_dom | PTPRD PTPRF PTPRJ COL6A3 FLNC COL7A1 LRFN1 COL12A1 FN1 TNC FNDC3A PTPRU TNN IL21R TNR TNXB EPHA4 EPHA7 | 1.34e-11 | 209 | 202 | 18 | IPR003961 |
| Domain | FN3 | PTPRD PTPRF PTPRJ COL6A3 COL7A1 LRFN1 COL12A1 FN1 TNC FNDC3A PTPRU TNN IL21R TNR TNXB EPHA4 EPHA7 | 5.76e-11 | 199 | 202 | 17 | PS50853 |
| Domain | Alpha_tubulin | 1.21e-10 | 9 | 202 | 6 | IPR002452 | |
| Domain | fn3 | PTPRD PTPRF PTPRJ COL7A1 LRFN1 COL12A1 FN1 TNC FNDC3A PTPRU TNN TNR TNXB EPHA4 EPHA7 | 2.60e-10 | 162 | 202 | 15 | PF00041 |
| Domain | Ig-like_fold | NRG1 GBE1 PTPRD PTPRF F11R PTPRJ ALPK3 KIT PLXNA1 PLXNA3 FLNB COL6A3 FLNC COL7A1 LRFN1 COL12A1 FN1 TNC ICAM1 FNDC3A BCAN PTPRU SHANK2 TNN IL21R TNR TNXB EPHA4 EPHA7 | 6.46e-10 | 706 | 202 | 29 | IPR013783 |
| Domain | - | NRG1 GBE1 PTPRD PTPRF F11R PTPRJ ALPK3 KIT PLXNA1 PLXNA3 FLNB COL6A3 FLNC COL7A1 LRFN1 COL12A1 FN1 TNC ICAM1 FNDC3A BCAN PTPRU TNN IL21R TNR TNXB EPHA4 EPHA7 | 7.07e-10 | 663 | 202 | 28 | 2.60.40.10 |
| Domain | Cadherin_C | 1.40e-08 | 42 | 202 | 8 | IPR032455 | |
| Domain | Cadherin_C_2 | 1.40e-08 | 42 | 202 | 8 | PF16492 | |
| Domain | Tubulin_C | 9.60e-08 | 22 | 202 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 9.60e-08 | 22 | 202 | 6 | IPR018316 | |
| Domain | Tubulin_C | 9.60e-08 | 22 | 202 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.29e-07 | 23 | 202 | 6 | IPR008280 | |
| Domain | Tubulin_C | 1.29e-07 | 23 | 202 | 6 | IPR023123 | |
| Domain | TUBULIN | 1.29e-07 | 23 | 202 | 6 | PS00227 | |
| Domain | Tubulin | 1.29e-07 | 23 | 202 | 6 | IPR000217 | |
| Domain | Tubulin | 1.29e-07 | 23 | 202 | 6 | SM00864 | |
| Domain | Tubulin_CS | 1.29e-07 | 23 | 202 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.70e-07 | 24 | 202 | 6 | IPR003008 | |
| Domain | Tubulin | 1.70e-07 | 24 | 202 | 6 | PF00091 | |
| Domain | - | 1.91e-06 | 20 | 202 | 5 | 3.30.1330.20 | |
| Domain | - | 2.49e-06 | 21 | 202 | 5 | 1.10.287.600 | |
| Domain | - | 3.19e-06 | 22 | 202 | 5 | 3.40.50.1440 | |
| Domain | EGF-like_dom | NRG1 ADAM18 FAT2 C1S NID2 FAT4 FRAS1 TNC BCAN TECTA TNN TNR TNXB | 3.34e-06 | 249 | 202 | 13 | IPR000742 |
| Domain | Peptidase_S9 | 4.13e-06 | 11 | 202 | 4 | PF00326 | |
| Domain | Peptidase_S9 | 4.13e-06 | 11 | 202 | 4 | IPR001375 | |
| Domain | EGF-like_CS | NRG1 ADAM18 FAT2 C1S NID2 FAT4 FN1 TNC BCAN TNN TNR TNXB EPHA7 | 5.58e-06 | 261 | 202 | 13 | IPR013032 |
| Domain | EGF_2 | 3.30e-05 | 265 | 202 | 12 | PS01186 | |
| Domain | EGF | 5.23e-05 | 235 | 202 | 11 | SM00181 | |
| Domain | EGF_3 | 5.23e-05 | 235 | 202 | 11 | PS50026 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 6.71e-05 | 8 | 202 | 3 | IPR019565 | |
| Domain | Thiol-ester_cl | 6.71e-05 | 8 | 202 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 6.71e-05 | 8 | 202 | 3 | IPR019742 | |
| Domain | EGF | 6.88e-05 | 126 | 202 | 8 | PF00008 | |
| Domain | EGF_1 | 1.09e-04 | 255 | 202 | 11 | PS00022 | |
| Domain | DUF3715 | 1.16e-04 | 2 | 202 | 2 | IPR022188 | |
| Domain | DUF3715 | 1.16e-04 | 2 | 202 | 2 | PF12509 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.19e-04 | 24 | 202 | 4 | IPR014715 | |
| Domain | - | 1.19e-04 | 24 | 202 | 4 | 4.10.530.10 | |
| Domain | A2M | 1.41e-04 | 10 | 202 | 3 | PF00207 | |
| Domain | A2M_N_2 | 1.41e-04 | 10 | 202 | 3 | IPR011625 | |
| Domain | A2M_comp | 1.41e-04 | 10 | 202 | 3 | IPR011626 | |
| Domain | A2M_recep | 1.41e-04 | 10 | 202 | 3 | PF07677 | |
| Domain | A2M_comp | 1.41e-04 | 10 | 202 | 3 | PF07678 | |
| Domain | A2M_N | 1.41e-04 | 10 | 202 | 3 | PF01835 | |
| Domain | A2M_N | 1.41e-04 | 10 | 202 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.41e-04 | 10 | 202 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.41e-04 | 10 | 202 | 3 | PS00477 | |
| Domain | A2M_N_2 | 1.41e-04 | 10 | 202 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 1.41e-04 | 10 | 202 | 3 | IPR001599 | |
| Domain | Fibrinogen_C | 1.92e-04 | 27 | 202 | 4 | PF00147 | |
| Domain | FBG | 2.55e-04 | 29 | 202 | 4 | SM00186 | |
| Domain | - | 2.92e-04 | 30 | 202 | 4 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 2.92e-04 | 30 | 202 | 4 | IPR014716 | |
| Domain | - | 3.15e-04 | 119 | 202 | 7 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.15e-04 | 119 | 202 | 7 | IPR029058 | |
| Domain | VWA | 3.44e-04 | 56 | 202 | 5 | PF00092 | |
| Domain | DUF2075 | 3.47e-04 | 3 | 202 | 2 | PF09848 | |
| Domain | DUF2075 | 3.47e-04 | 3 | 202 | 2 | IPR018647 | |
| Domain | FIBRINOGEN_C_1 | 3.77e-04 | 32 | 202 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.77e-04 | 32 | 202 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.77e-04 | 32 | 202 | 4 | PS51406 | |
| Domain | PTPc_motif | 4.39e-04 | 59 | 202 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 4.39e-04 | 59 | 202 | 5 | IPR003595 | |
| Domain | EGF_extracell | 4.75e-04 | 60 | 202 | 5 | IPR013111 | |
| Domain | EGF_2 | 4.75e-04 | 60 | 202 | 5 | PF07974 | |
| Domain | PTPc | 5.97e-04 | 36 | 202 | 4 | SM00194 | |
| Domain | VWF_A | 7.23e-04 | 99 | 202 | 6 | IPR002035 | |
| Domain | TYR_PHOSPHATASE_PTP | 8.12e-04 | 39 | 202 | 4 | PS50055 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 9.02e-04 | 18 | 202 | 3 | IPR008930 | |
| Domain | Ig_E-set | 9.36e-04 | 104 | 202 | 6 | IPR014756 | |
| Domain | PTPase_domain | 9.83e-04 | 41 | 202 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 9.83e-04 | 41 | 202 | 4 | PF00102 | |
| Domain | NIDO_dom | 1.14e-03 | 5 | 202 | 2 | IPR003886 | |
| Domain | NIDO | 1.14e-03 | 5 | 202 | 2 | SM00539 | |
| Domain | NIDO | 1.14e-03 | 5 | 202 | 2 | PF06119 | |
| Domain | Anaphylatoxin_comp_syst | 1.14e-03 | 5 | 202 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.14e-03 | 5 | 202 | 2 | IPR001840 | |
| Domain | NIDO | 1.14e-03 | 5 | 202 | 2 | PS51220 | |
| Domain | Nlgn | 1.14e-03 | 5 | 202 | 2 | IPR000460 | |
| Domain | FATC | 1.14e-03 | 5 | 202 | 2 | PF02260 | |
| Domain | - | 1.24e-03 | 74 | 202 | 5 | 3.40.50.410 | |
| Domain | Growth_fac_rcpt_ | 1.56e-03 | 156 | 202 | 7 | IPR009030 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 2.140.10.30 | |
| Domain | DPPIV_N | 1.70e-03 | 6 | 202 | 2 | PF00930 | |
| Domain | FAT | 1.70e-03 | 6 | 202 | 2 | PS51189 | |
| Domain | FATC | 1.70e-03 | 6 | 202 | 2 | PS51190 | |
| Domain | FATC_dom | 1.70e-03 | 6 | 202 | 2 | IPR003152 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.38e-11 | 21 | 156 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.15e-10 | 17 | 156 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.10e-10 | 18 | 156 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.00e-10 | 19 | 156 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.00e-10 | 19 | 156 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.22e-09 | 20 | 156 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.22e-09 | 20 | 156 | 7 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.81e-09 | 21 | 156 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 2.63e-09 | 22 | 156 | 7 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.75e-09 | 23 | 156 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.75e-09 | 23 | 156 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.75e-09 | 23 | 156 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 5.25e-09 | 24 | 156 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.25e-09 | 24 | 156 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.22e-09 | 25 | 156 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.22e-09 | 25 | 156 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 9.79e-09 | 26 | 156 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.79e-09 | 26 | 156 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 1.73e-08 | 28 | 156 | 7 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 2.26e-08 | 29 | 156 | 7 | M27948 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 ITGAM F11R NID2 COL6A3 COL7A1 COL12A1 FN1 TNC ICAM1 BCAN TNN CTSB TNR TNXB CAPN15 | 2.69e-08 | 258 | 156 | 16 | MM14572 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.10e-08 | 47 | 156 | 8 | MM14925 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 4.74e-08 | 32 | 156 | 7 | M27491 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 4.74e-08 | 32 | 156 | 7 | M29848 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 5.96e-08 | 33 | 156 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 5.96e-08 | 33 | 156 | 7 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 9.21e-08 | 35 | 156 | 7 | M47774 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.47e-07 | 55 | 156 | 8 | M39613 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.68e-07 | 38 | 156 | 7 | M14981 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.70e-07 | 56 | 156 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.96e-07 | 57 | 156 | 8 | M27251 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A5 ITGAM F11R NID2 COL6A3 COL7A1 COL12A1 FN1 TNC ICAM1 BCAN TNN CTSB TNR TNXB CAPN15 | 2.16e-07 | 300 | 156 | 16 | M610 |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 4.10e-07 | 43 | 156 | 7 | M47773 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.10e-07 | 43 | 156 | 7 | M47669 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 4.83e-07 | 44 | 156 | 7 | M27934 | |
| Pathway | REACTOME_AGGREPHAGY | 4.83e-07 | 44 | 156 | 7 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.66e-07 | 45 | 156 | 7 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.62e-07 | 46 | 156 | 7 | M27828 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 8.65e-07 | 17 | 156 | 5 | MM14731 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A HSPA1L FLNB RANBP2 TUBA3D TUBA1C ABCE1 | 9.09e-07 | 151 | 156 | 11 | M550 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.03e-06 | 49 | 156 | 7 | M891 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.11e-06 | 71 | 156 | 8 | M39690 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL6A5 TUBA8 TUBA1B TUBA1A PLXNA1 PLXNA3 COL6A3 TUBA3D TUBA1C RET ACTR2 ROCK1 EPHA4 EPHA7 | 1.20e-06 | 261 | 156 | 14 | MM15676 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.37e-06 | 51 | 156 | 7 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.79e-06 | 53 | 156 | 7 | M27651 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.87e-06 | 76 | 156 | 8 | M48037 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.87e-06 | 76 | 156 | 8 | MM14867 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.87e-06 | 76 | 156 | 8 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.40e-06 | 85 | 156 | 8 | M16441 | |
| Pathway | REACTOME_KINESINS | 4.69e-06 | 61 | 156 | 7 | M977 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 9.35e-06 | 94 | 156 | 8 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 9.35e-06 | 94 | 156 | 8 | MM14515 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.03e-05 | 27 | 156 | 5 | MM15674 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.03e-05 | 27 | 156 | 5 | MM15549 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.08e-05 | 126 | 156 | 9 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.15e-05 | 127 | 156 | 9 | M27181 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.27e-05 | 98 | 156 | 8 | M776 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | NRG1 TUBA3E TUBA8 KCNB2 TUBA3C TUBA1B NLGN3 PTPRD KCNA5 PTPRF TUBA1A NLGN2 LRFN1 TUBA3D TUBA1C SHANK2 | 1.30e-05 | 411 | 156 | 16 | M735 |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.43e-05 | 72 | 156 | 7 | M26954 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.49e-05 | 29 | 156 | 5 | MM15219 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.05e-05 | 76 | 156 | 7 | M27215 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.23e-05 | 52 | 156 | 6 | MM14949 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.46e-05 | 32 | 156 | 5 | MM14730 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.52e-05 | 140 | 156 | 9 | M27550 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.64e-05 | 79 | 156 | 7 | M27743 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.78e-05 | 54 | 156 | 6 | M27482 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.84e-05 | 114 | 156 | 8 | MM14571 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.94e-05 | 84 | 156 | 7 | M7098 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL6A5 TUBA8 TUBA1B TUBA1A KIT PLXNA1 PLXNA3 COL6A3 DSG2 TUBA3D TUBA1C RET ACTR2 ROCK1 CDH15 EPHA4 EPHA7 | 4.10e-05 | 502 | 156 | 17 | MM14537 |
| Pathway | REACTOME_AGGREPHAGY | 4.45e-05 | 36 | 156 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.10e-05 | 37 | 156 | 5 | MM15102 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A HSPA1L FLNB RANBP2 TUBA3D TUBA1C ICAM1 ABCE1 | 5.17e-05 | 273 | 156 | 12 | M983 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A COL7A1 TUBA3D TUBA1C SEC24C | 5.90e-05 | 156 | 156 | 9 | M27097 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 6.09e-05 | 20 | 156 | 4 | MM1383 | |
| Pathway | KEGG_GAP_JUNCTION | 6.15e-05 | 90 | 156 | 7 | M4013 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 6.15e-05 | 90 | 156 | 7 | M29841 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 7.15e-05 | 8 | 156 | 3 | M47872 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.36e-05 | 199 | 156 | 10 | M7253 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3E TUBA8 BBS9 TUBA3C TUBA1B TUBA1A PKD1 IFT22 TUBA3D TUBA1C | 8.00e-05 | 201 | 156 | 10 | M27472 |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 8.69e-05 | 95 | 156 | 7 | M6729 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 8.76e-05 | 66 | 156 | 6 | MM17074 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA3E TUBA8 NEK9 TUBA3C TUBA1B TUBA1A RANBP2 TUBA3D TUBA1C BUB3 | 9.05e-05 | 204 | 156 | 10 | M4217 |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 1.14e-04 | 133 | 156 | 8 | M16476 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.19e-04 | 44 | 156 | 5 | MM14606 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.20e-04 | 100 | 156 | 7 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.36e-04 | 102 | 156 | 7 | M27648 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.48e-04 | 138 | 156 | 8 | MM15635 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 1.48e-04 | 138 | 156 | 8 | M29805 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 1.54e-04 | 73 | 156 | 6 | MM15126 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.63e-04 | 140 | 156 | 8 | M587 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.66e-04 | 74 | 156 | 6 | M160 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.82e-04 | 48 | 156 | 5 | MM15353 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.82e-04 | 48 | 156 | 5 | MM15069 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | RPS3 TUBA3E COL6A5 TUBA8 TUBA3C TUBA1B TUBA1A PLXNA1 PLXNA3 COL6A3 TUBA3D TUBA1C RET ACTR2 ROCK1 EPHA4 EPHA7 | 2.13e-04 | 575 | 156 | 17 | M29853 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.21e-04 | 50 | 156 | 5 | MM14796 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A COL7A1 TUBA3D TUBA1C SEC24C | 2.35e-04 | 187 | 156 | 9 | M961 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 2.66e-04 | 52 | 156 | 5 | MM15211 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.72e-04 | 12 | 156 | 3 | MM1368 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.74e-04 | 191 | 156 | 9 | M29614 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.91e-04 | 53 | 156 | 5 | MM14566 | |
| Pubmed | PCDHA9 PCDHB5 FAT2 PCDH18 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 7.72e-24 | 77 | 212 | 18 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA9 PCDHB5 FAT2 PCDH18 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 1.65e-23 | 80 | 212 | 18 | 10716726 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA9 PCDHB5 FAT2 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 1.16e-22 | 72 | 212 | 17 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA9 PCDHB5 PCDH18 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 1.95e-22 | 74 | 212 | 17 | 10817752 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA9 PCDHB5 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 2.27e-21 | 68 | 212 | 16 | 11230163 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA9 PCDHB5 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.35e-21 | 57 | 212 | 15 | 32633719 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA9 PCDHGC5 PCDHGA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.36e-20 | 28 | 212 | 12 | 15347688 |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.67e-19 | 15 | 212 | 10 | 15640798 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA9 PCDHB5 PCDHGC5 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.07e-19 | 58 | 212 | 14 | 30377227 |
| Pubmed | PCDHA9 PCDHB5 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.74e-19 | 24 | 212 | 11 | 24698270 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.07e-18 | 17 | 212 | 10 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.40e-18 | 18 | 212 | 10 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.40e-18 | 18 | 212 | 10 | 10662547 |
| Pubmed | 1.01e-14 | 9 | 212 | 7 | 21167302 | ||
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 9.15e-14 | 11 | 212 | 7 | 9655502 | |
| Pubmed | 1.34e-11 | 19 | 212 | 7 | 15698476 | ||
| Pubmed | 1.34e-11 | 19 | 212 | 7 | 15691386 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.36e-11 | 75 | 212 | 10 | 15372022 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 4.28e-11 | 12 | 212 | 6 | 10612399 | |
| Pubmed | 4.47e-11 | 22 | 212 | 7 | 28117675 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 ASMT | 1.97e-10 | 119 | 212 | 11 | 28625976 |
| Pubmed | 2.02e-10 | 64 | 212 | 9 | 22261194 | ||
| Pubmed | PDHA1 RPS3 CDKL5 NLGN3 FASN TUBA1A PLEKHA5 C4A MICAL3 C4B NOS1 PITPNM2 FLNB FLNC FN1 SELENBP1 CORO2A TNC PCLO TUBA1C TOM1 BCAN UPF1 ACTR2 SHANK2 APPL2 SEC24C PRKCE TANC1 TNR TNS1 DCLK1 | 2.27e-10 | 1431 | 212 | 32 | 37142655 | |
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 4.43e-10 | 8 | 212 | 5 | 16148047 | |
| Pubmed | FAT2 PTPRF PTPRJ C1S C4A KIT COL6A3 FN1 DSG2 TNC ICAM1 TNN CDH5 TNXB | 7.59e-10 | 257 | 212 | 14 | 16335952 | |
| Pubmed | PCDHA9 KCNB2 CDKL5 PKD1 FLNB FLNC PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA3 PCDHA2 PCDHA1 CRK SHANK2 | 2.14e-09 | 329 | 212 | 15 | 17474147 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 3.29e-09 | 22 | 212 | 6 | 23826228 | |
| Pubmed | 6.14e-09 | 12 | 212 | 5 | 10101119 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 6.14e-09 | 12 | 212 | 5 | 15331610 | |
| Pubmed | 6.68e-09 | 5 | 212 | 4 | 9382884 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 9.93e-09 | 13 | 212 | 5 | 10908577 | |
| Pubmed | 1.54e-08 | 14 | 212 | 5 | 12486001 | ||
| Pubmed | Abnormal neocortex arealization and Sotos-like syndrome-associated behavior in Setd2 mutant mice. | 1.61e-08 | 28 | 212 | 6 | 33523829 | |
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 1.99e-08 | 6 | 212 | 4 | 11773012 | |
| Pubmed | 1.99e-08 | 6 | 212 | 4 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.99e-08 | 6 | 212 | 4 | 7651436 | |
| Pubmed | 1.99e-08 | 6 | 212 | 4 | 16327313 | ||
| Pubmed | 1.99e-08 | 6 | 212 | 4 | 24259506 | ||
| Pubmed | RPS3 TUBA3E TUBA8 NEB TUBA3C TUBA1B TUBA1A TAF7L HSPA1L COL6A3 FAT4 FRAS1 PCDHGC5 TECTA CBR3 TRAP1 CAPN15 | 2.08e-08 | 513 | 212 | 17 | 25798074 | |
| Pubmed | MAGI1 TMEM132B NEK9 NLGN3 PTPRD PLEKHA5 NLGN2 MGA NOS1 RANBP2 LRFN1 FXR2 UPF1 SHANK2 SEC24C ROCK1 PRKCE BUB3 PARD3 TNR TNS1 DCLK1 EPHA4 | 2.93e-08 | 963 | 212 | 23 | 28671696 | |
| Pubmed | 4.63e-08 | 7 | 212 | 4 | 11146551 | ||
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 9.22e-08 | 8 | 212 | 4 | 10072631 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 NRG1 CDKL5 PTPRF F11R PTPRJ PLEKHA5 MICAL3 PCDH18 PLXNA1 DSG2 SLC12A2 ROCK1 TANC1 PARD3 EPHA4 EPHA7 | 9.23e-08 | 569 | 212 | 17 | 30639242 |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.58e-07 | 135 | 212 | 9 | 28675934 | |
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 1.65e-07 | 9 | 212 | 4 | 11953448 | |
| Pubmed | 1.94e-07 | 22 | 212 | 5 | 15103018 | ||
| Pubmed | 1.94e-07 | 22 | 212 | 5 | 27527664 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 30465166 | ||
| Pubmed | Structural Basis of Diverse Homophilic Recognition by Clustered α- and β-Protocadherins. | 2.23e-07 | 3 | 212 | 3 | 27161523 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 7530141 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 25703008 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 19137635 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 2.23e-07 | 3 | 212 | 3 | 7694605 | |
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 2.23e-07 | 3 | 212 | 3 | 7687262 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | RPS3 TUBA3E TUBA8 TUBA3C TUBA1B FASN TUBA1A HSPA1L FLNB DSG2 TUBA1C TRAP1 | 2.38e-07 | 288 | 212 | 12 | 31501420 |
| Pubmed | SMG1 ACACB PABPC5 CNPY2 NEB TASOR2 FASN TASOR HSPA1L FBXO15 BAHCC1 PLXNA3 FLNB FLNC RANBP2 PCDHGC5 PCDHGA9 PCLO SRBD1 ACTR2 TRAP1 SHANK2 GTF3C1 TNN ATG4C PCDHGA8 EPHA4 | 2.45e-07 | 1442 | 212 | 27 | 35575683 | |
| Pubmed | RPS3 TUBA8 PGM3 TUBA1B TUBA1A PKD1 HSPA1L PLXNA1 COL6A3 TRAP1 | 2.53e-07 | 187 | 212 | 10 | 26460568 | |
| Pubmed | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.39e-07 | 193 | 212 | 10 | 22589738 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ATR TMEM165 CNPY2 NEK9 HSPA13 PTPRF PTPRJ NADK PLEKHA5 C4A FAM8A1 QSOX2 PLXNA1 SEL1L PLXNA3 COL7A1 FAT4 FRAS1 COL12A1 DSG2 SLC12A2 GTF3C1 SEC24C ABCE1 | 3.83e-07 | 1201 | 212 | 24 | 35696571 |
| Pubmed | MAGI1 ATP7A RPS3 ZC3H15 TMEM165 FASN PLEKHA5 MICAL3 FLNB RANBP2 DSG2 FNDC3A UPF1 CRK SEC24C ABCE1 ROCK1 PARD3 | 4.12e-07 | 708 | 212 | 18 | 39231216 | |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 4.28e-07 | 11 | 212 | 4 | 10686478 | |
| Pubmed | RPS3 TUBA3E TUBA8 TUBA3C TUBA1B TUBA1A FLNC TUBA3D TUBA1C ICAM1 | 8.01e-07 | 212 | 212 | 10 | 23463506 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 19135723 | ||
| Pubmed | Extracellular matrix alterations in brains lacking four of its components. | 8.89e-07 | 4 | 212 | 3 | 15694392 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 10207042 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 31558805 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 35721494 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 2777798 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 18400243 | ||
| Pubmed | Neural extracellular matrix regulates visual sensory motor integration. | 8.89e-07 | 4 | 212 | 3 | 38318351 | |
| Pubmed | Two steroid 21-hydroxylase genes are located in the murine S region. | 8.89e-07 | 4 | 212 | 3 | 6095106 | |
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 29367009 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 23637166 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 3856857 | ||
| Pubmed | 8.89e-07 | 4 | 212 | 3 | 28512860 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.01e-06 | 86 | 212 | 7 | 28327460 | |
| Pubmed | 1.41e-06 | 175 | 212 | 9 | 28071719 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDHA1 RPS3 TUBA8 PHF2 TUBA1B FASN TUBA1A TDRD6 NOS1 PCLO BCAN TRAP1 ROCK1 PRKCE PARD3 DCLK1 | 1.56e-06 | 621 | 212 | 16 | 22794259 |
| Pubmed | RPS3 NEK9 TASOR2 TUBA1B FASN MGA TASOR FLNB FLNC EXOSC9 CDKN2AIP UPF1 SRBD1 SEC24C ROCK1 | 1.71e-06 | 551 | 212 | 15 | 34728620 | |
| Pubmed | 1.85e-06 | 94 | 212 | 7 | 36584595 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 2652811 | ||
| Pubmed | The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. | 2.21e-06 | 5 | 212 | 3 | 7512972 | |
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 34888534 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 21393236 | ||
| Pubmed | 2.21e-06 | 5 | 212 | 3 | 6316336 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAGI1 ZC3H15 CDKL5 FASN F11R PTPRJ PLEKHA5 FLNB DSG2 CRK SHANK2 SLC12A2 TANC1 PARD3 CTSB | 2.32e-06 | 565 | 212 | 15 | 25468996 |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 2.45e-06 | 98 | 212 | 7 | 21942715 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPS3 FASN GRHPR HSPA1L FLNB FLNC SELENBP1 TUBA3D PCLO TUBA1C AGR2 PCDHA8 UPF1 ACTR2 TRAP1 SLC12A2 ABCE1 BUB3 | 2.63e-06 | 807 | 212 | 18 | 30575818 |
| Pubmed | MAGI1 CDKL5 NLGN3 NLGN2 FN1 CORO2A FXR2 TNC UPF1 ACTR2 APPL2 PARD3 TNR | 2.75e-06 | 430 | 212 | 13 | 32581705 | |
| Pubmed | 3.00e-06 | 17 | 212 | 4 | 17360745 | ||
| Pubmed | DCHS2 TRAF6 ZNF202 FTCD CNOT8 HSPA13 TUBA1B PTPRD GRHPR PKD1 RNF10 C1S SOX6 FLNB EXOSC9 FN1 CORO2A SIM2 CBR3 POLR3B APPL2 CTSB DCLK1 | 4.30e-06 | 1285 | 212 | 23 | 35914814 | |
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 19273906 | ||
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 12090300 | ||
| Pubmed | 4.41e-06 | 6 | 212 | 3 | 10840040 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GBE1 FTCD NEB FASN PTPRJ GRHPR TUBA1A PKD1 CRB3 FLNB COL6A3 FN1 SELENBP1 GDPD3 ICAM1 TOM1 TECTA ACTR2 CRK APPL2 | 4.73e-06 | 1016 | 212 | 20 | 19056867 |
| Pubmed | ATP7A ACACB RPS3 TASOR2 CDKL5 MGA TASOR FAT4 REXO4 FN1 DSG2 TUBA1C MUC16 SLC12A2 SEC24C SLFN13 PARD3 | 6.48e-06 | 777 | 212 | 17 | 35844135 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR PDHA1 RPS3 ZC3H15 RGS22 NEK9 PHF2 TUBA1B FASN TDRD6 PLXNA1 FLNB RANBP2 EXOSC9 REXO4 DSG2 PCLO TUBA1C UPF1 ACTR2 TRAP1 GTF3C1 ABCE1 BUB3 | 7.31e-06 | 1425 | 212 | 24 | 30948266 |
| Pubmed | 7.40e-06 | 21 | 212 | 4 | 36332009 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PDHA1 RPS3 PGM3 TUBA1B FASN GRHPR TUBA1A PCYT2 RANBP2 EXOSC9 FNDC3A UPF1 POLR3B GTF3C1 SEC24C ABCE1 | 7.64e-06 | 704 | 212 | 16 | 29955894 |
| Pubmed | 7.68e-06 | 7 | 212 | 3 | 16059920 | ||
| Interaction | PCDHA10 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 | 4.95e-13 | 22 | 208 | 9 | int:PCDHA10 |
| Interaction | PCDHA8 interactions | AGR2 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.16e-10 | 55 | 208 | 10 | int:PCDHA8 |
| Interaction | PCDHA7 interactions | 3.15e-09 | 14 | 208 | 6 | int:PCDHA7 | |
| Interaction | TCP11L2 interactions | 5.36e-08 | 21 | 208 | 6 | int:TCP11L2 | |
| Interaction | IFNE interactions | 2.78e-07 | 27 | 208 | 6 | int:IFNE | |
| Interaction | PCDHA9 interactions | 8.15e-07 | 32 | 208 | 6 | int:PCDHA9 | |
| Interaction | PCDHA11 interactions | 1.15e-06 | 19 | 208 | 5 | int:PCDHA11 | |
| Interaction | PCDHA3 interactions | 1.19e-06 | 34 | 208 | 6 | int:PCDHA3 | |
| Interaction | PCDHGB1 interactions | 1.29e-06 | 77 | 208 | 8 | int:PCDHGB1 | |
| Interaction | PCDHA1 interactions | 1.33e-06 | 9 | 208 | 4 | int:PCDHA1 | |
| Interaction | RYK interactions | HSPA13 PTPRD PTPRF NLGN2 PCDH18 FAT4 SELENBP1 DSG2 TRAP1 CDH5 EPHA4 EPHA7 | 2.19e-06 | 212 | 208 | 12 | int:RYK |
| Interaction | CTNNA1 interactions | MAGI1 PDHA1 HSPA13 FASN PTPRQ PKD1 PLEKHA5 DSG2 AGR2 PTPRU PARD3 CDH5 CDH15 EPHA4 EPHA7 | 3.44e-06 | 347 | 208 | 15 | int:CTNNA1 |
| Interaction | LTBP1 interactions | 4.99e-06 | 92 | 208 | 8 | int:LTBP1 | |
| Interaction | AFDN interactions | MAGI1 KCNB2 CDKL5 F11R PLEKHA5 LRFN1 FN1 DSG2 PTPRU SLC12A2 ROCK1 PARD3 DCLK1 EPHA7 | 1.00e-05 | 333 | 208 | 14 | int:AFDN |
| Interaction | NEK4 interactions | NRG1 RPS3 TUBA3E TUBA8 NEB TUBA3C TUBA1B TUBA1A TAF7L HSPA1L COL6A3 FAT4 FRAS1 PCDHGC5 PCDHA12 TECTA CBR3 TRAP1 CAPN15 | 1.03e-05 | 582 | 208 | 19 | int:NEK4 |
| Interaction | DOK3 interactions | 2.63e-05 | 57 | 208 | 6 | int:DOK3 | |
| Interaction | PINK1 interactions | TRAF6 ATR RPS3 TUBA1B FASN TUBA1A A2ML1 C4A C4B HSPA1L FLNB FLNC RANBP2 DSG2 GDPD3 TUBA1C AGR2 CBR3 TRAP1 APPL2 | 2.64e-05 | 679 | 208 | 20 | int:PINK1 |
| Interaction | AGAP1 interactions | 2.93e-05 | 117 | 208 | 8 | int:AGAP1 | |
| Interaction | GABRA1 interactions | 2.93e-05 | 152 | 208 | 9 | int:GABRA1 | |
| Interaction | PCDHA4 interactions | 3.54e-05 | 60 | 208 | 6 | int:PCDHA4 | |
| Interaction | FLOT1 interactions | MAGI1 SLC9A9 PDHA1 KCNB2 PLEKHA5 SEL1L SOX6 FN1 DSG2 PCLO TUBA1C SLC12A2 ABCE1 ROCK1 TANC1 PARD3 | 3.63e-05 | 475 | 208 | 16 | int:FLOT1 |
| Interaction | GRM7 interactions | 3.78e-05 | 19 | 208 | 4 | int:GRM7 | |
| Interaction | PCDHGA10 interactions | 3.78e-05 | 19 | 208 | 4 | int:PCDHGA10 | |
| Interaction | KCTD13 interactions | PDHA1 RPS3 CDKL5 NLGN3 FASN TUBA1A PLEKHA5 MICAL3 HSPA1L NOS1 PITPNM2 FLNB FLNC FN1 CORO2A TNC PCLO TUBA1C TOM1 BCAN UPF1 ACTR2 CRK SHANK2 APPL2 SEC24C PRKCE TANC1 TNR TNS1 DCLK1 | 4.24e-05 | 1394 | 208 | 31 | int:KCTD13 |
| Interaction | OAZ1 interactions | 4.25e-05 | 38 | 208 | 5 | int:OAZ1 | |
| Interaction | CDH1 interactions | MAGI1 ZC3H15 CDKL5 FASN PTPRD PTPRF F11R PTPRJ PTPRQ PKD1 PLEKHA5 FLNB DSG2 UPF1 CRK SHANK2 SLC12A2 ROCK1 TANC1 PARD3 CTSB | 4.87e-05 | 768 | 208 | 21 | int:CDH1 |
| Interaction | DHFR2 interactions | ADAM18 TUBA1B TUBA1A NLGN2 HERC1 HSPA1L PCDHGA9 PCDHA12 FNDC3A PTPRU SLC12A2 TAS1R2 | 4.92e-05 | 289 | 208 | 12 | int:DHFR2 |
| Interaction | STARD13 interactions | 7.23e-05 | 68 | 208 | 6 | int:STARD13 | |
| Interaction | PCDHA6 interactions | 8.70e-05 | 9 | 208 | 3 | int:PCDHA6 | |
| Interaction | FLT3 interactions | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TRAP1 ASMT | 1.22e-04 | 318 | 208 | 12 | int:FLT3 |
| Interaction | DHX58 interactions | 1.38e-04 | 26 | 208 | 4 | int:DHX58 | |
| Interaction | CDH5 interactions | 1.38e-04 | 109 | 208 | 7 | int:CDH5 | |
| Interaction | TNIK interactions | TRAF6 CDKL5 PTPRD PLEKHA5 NLGN2 MGA NOS1 FXR2 SHANK2 SEC24C TNR DCLK1 EPHA7 | 1.74e-04 | 381 | 208 | 13 | int:TNIK |
| Interaction | EPHA7 interactions | TUBA1A PLEKHA5 PLXNA1 IL17RB PLXNA3 NID2 DSG2 SLC12A2 PARD3 EPHA4 EPHA7 | 1.76e-04 | 282 | 208 | 11 | int:EPHA7 |
| Interaction | H2BC5 interactions | PTPRF HERC1 REXO4 PCDHGC5 PCDHGA9 PCLO ICAM1 NECAP1 TNN ATG4C SLFN11 PCDHGA8 | 1.77e-04 | 331 | 208 | 12 | int:H2BC5 |
| Interaction | PTPRB interactions | 1.78e-04 | 51 | 208 | 5 | int:PTPRB | |
| Interaction | LGALS1 interactions | DPP8 NLGN3 PTPRD PTPRJ PLXNA1 NID2 FAT4 FRAS1 FN1 AGR2 MUC16 TRAP1 | 1.82e-04 | 332 | 208 | 12 | int:LGALS1 |
| Interaction | CEACAM21 interactions | 1.92e-04 | 81 | 208 | 6 | int:CEACAM21 | |
| Interaction | KCNC3 interactions | 2.14e-04 | 29 | 208 | 4 | int:KCNC3 | |
| Cytoband | 5q31 | PCDHA9 PCDHB5 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 2.41e-19 | 115 | 212 | 16 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA9 PCDHB5 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 9.45e-13 | 298 | 212 | 16 | chr5q31 |
| Cytoband | 16p11 | 4.39e-04 | 7 | 212 | 2 | 16p11 | |
| GeneFamily | Clustered protocadherins | PCDHA9 PCDHB5 PCDHGC5 PCDHGA9 PCDHB13 PCDHB8 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PCDHGA8 | 1.33e-19 | 64 | 155 | 16 | 20 |
| GeneFamily | Fibronectin type III domain containing | PTPRD PTPRF PTPRJ PTPRQ COL7A1 LRFN1 COL12A1 FN1 TNC FNDC3A PTPRU TNN TNR TNXB EPHA4 EPHA7 | 5.47e-13 | 160 | 155 | 16 | 555 |
| GeneFamily | Tubulins | 1.70e-09 | 26 | 155 | 7 | 778 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.91e-07 | 21 | 155 | 5 | 813 | |
| GeneFamily | Cadherin related | 1.13e-05 | 17 | 155 | 4 | 24 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 5.00e-05 | 9 | 155 | 3 | 1234 | |
| GeneFamily | Fibrinogen C domain containing | 5.71e-05 | 25 | 155 | 4 | 554 | |
| GeneFamily | Complement system|Sushi domain containing | 2.47e-04 | 36 | 155 | 4 | 492 | |
| GeneFamily | Collagens | 6.41e-04 | 46 | 155 | 4 | 490 | |
| GeneFamily | Schlafen family | 1.49e-03 | 7 | 155 | 2 | 1110 | |
| GeneFamily | CD molecules|DASH family | 1.49e-03 | 7 | 155 | 2 | 1205 | |
| GeneFamily | Plexins | 2.53e-03 | 9 | 155 | 2 | 683 | |
| GeneFamily | Doublecortin superfamily | 3.14e-03 | 10 | 155 | 2 | 1369 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 6.21e-03 | 14 | 155 | 2 | 1095 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 PCDHB5 TAF7L NLGN2 NOS1 BAHCC1 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.96e-09 | 261 | 212 | 15 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA9 PCDHB5 TAF7L NLGN2 NOS1 BAHCC1 PCDHA13 PCDHA12 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.87e-09 | 238 | 212 | 14 | M2020 |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.41e-07 | 33 | 212 | 6 | M7409 | |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC BCAN TECTA TNN TNR TNXB | 3.44e-07 | 270 | 212 | 13 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL6A5 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC BCAN TECTA TNN TNR TNXB | 4.24e-07 | 275 | 212 | 13 | M5884 |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 9.07e-07 | 93 | 212 | 8 | MM1266 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 5.57e-06 | 32 | 212 | 5 | MM657 | |
| Coexpression | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED | 6.41e-06 | 86 | 212 | 7 | M1968 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 9.12e-06 | 17 | 212 | 4 | M47995 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 3.73e-05 | 199 | 212 | 9 | M8100 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 3.73e-05 | 199 | 212 | 9 | M4567 | |
| Coexpression | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP | 5.00e-05 | 160 | 212 | 8 | M986 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 5.87e-05 | 211 | 212 | 9 | M12225 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 6.31e-05 | 27 | 212 | 4 | M47994 | |
| Coexpression | NABA_MATRISOME | NRG1 ADAM18 COL6A5 A2ML1 PLXNA1 PLXNA3 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC NTF3 MUC16 BCAN TECTA TNN CTSB TNR TNXB | 7.51e-05 | 1008 | 212 | 21 | MM17056 |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 8.14e-05 | 88 | 212 | 6 | M5360 | |
| Coexpression | NABA_MATRISOME | NRG1 ADAM18 COL6A5 A2ML1 PLXNA1 PLXNA3 NID2 COL6A3 COL7A1 FRAS1 COL12A1 FN1 TNC NTF3 MUC16 BCAN TECTA TNN CTSB TNR TNXB | 9.62e-05 | 1026 | 212 | 21 | M5889 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | WDR90 FLNC COL7A1 FN1 TNC PCDHA13 PCDHA12 PCDHA6 PCDHA4 PCDHA1 SLC12A2 UPK3BL1 | 2.27e-05 | 281 | 208 | 12 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | WDR90 FLNC COL7A1 FN1 TNC PCDHA13 PCDHA12 PCDHA6 PCDHA4 PCDHA1 SLC12A2 UPK3BL1 | 2.27e-05 | 281 | 208 | 12 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL6A5 TMEM59L C1S C4A PCDH18 COL6A3 FAT4 COL12A1 FN1 TNC TNN TNXB EPHA7 | 3.95e-12 | 180 | 211 | 13 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | PCDHB5 PABPC5 PTPRD ARNT2 TMEM59L C1S NLGN2 PCDH18 COL12A1 TNC PCDHA3 MORC4 | 1.85e-10 | 196 | 211 | 12 | 614a07334707eafe238d5cb7b080a3ca796a1920 |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | COL6A5 C1S PCDH18 FLNB COL6A3 FAT4 COL12A1 FN1 TNC NTF3 TNXB EPHA7 | 2.20e-10 | 199 | 211 | 12 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | TUBA8 PPM1J TMEM132B NLGN3 KCNA5 GNA15 BAHCC1 FLNB BCAN RET SV2C CTSB | 2.77e-10 | 203 | 211 | 12 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC9A9 INPP4B PCDH18 NID2 COL6A3 COL12A1 TNC TANC1 TNXB DCLK1 | 9.18e-09 | 170 | 211 | 10 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SLC9A9 INPP4B PCDH18 NID2 COL6A3 COL12A1 TNC TANC1 TNXB DCLK1 | 9.18e-09 | 170 | 211 | 10 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL6A5 TMEM132B TMEM59L C1S NID2 COL6A3 COL12A1 FN1 TNC PCDHGA8 | 1.67e-08 | 181 | 211 | 10 | c62b0a2422377ffadaab63edd538e87a06fa5017 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | COL6A5 TMEM132B TMEM59L C1S NID2 COL6A3 COL12A1 FN1 TNC PCDHGA8 | 1.67e-08 | 181 | 211 | 10 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | CDKL5 PTPRF PTPRQ PLXNA1 SOX6 NID2 FRAS1 SELENBP1 PTPRU SHANK2 | 3.91e-08 | 198 | 211 | 10 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-08 | 198 | 211 | 10 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-08 | 198 | 211 | 10 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 4.09e-08 | 149 | 211 | 9 | 75422e1a22736375e9ef439db0b2a5efa3f653a3 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 4.10e-08 | 199 | 211 | 10 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.10e-08 | 199 | 211 | 10 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.10e-08 | 199 | 211 | 10 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.30e-08 | 200 | 211 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.30e-08 | 200 | 211 | 10 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-08 | 160 | 211 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-08 | 160 | 211 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.27e-07 | 170 | 211 | 9 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-07 | 177 | 211 | 9 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-07 | 177 | 211 | 9 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.27e-07 | 182 | 211 | 9 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 184 | 211 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 184 | 211 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-07 | 184 | 211 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.60e-07 | 185 | 211 | 9 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-07 | 189 | 211 | 9 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-07 | 189 | 211 | 9 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-07 | 190 | 211 | 9 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-07 | 191 | 211 | 9 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-07 | 192 | 211 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-07 | 192 | 211 | 9 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.72e-07 | 193 | 211 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-07 | 194 | 211 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-07 | 194 | 211 | 9 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 195 | 211 | 9 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-07 | 195 | 211 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.24e-07 | 196 | 211 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-07 | 196 | 211 | 9 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.61e-07 | 198 | 211 | 9 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 4.61e-07 | 198 | 211 | 9 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 199 | 211 | 9 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 199 | 211 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-07 | 199 | 211 | 9 | fb580e9321ddf97c73b2e356cd82523db74a38a2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 199 | 211 | 9 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.81e-07 | 199 | 211 | 9 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-07 | 199 | 211 | 9 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.81e-07 | 199 | 211 | 9 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.02e-07 | 200 | 211 | 9 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-07 | 200 | 211 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.02e-07 | 200 | 211 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.02e-07 | 200 | 211 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-07 | 200 | 211 | 9 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-07 | 200 | 211 | 9 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-07 | 200 | 211 | 9 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.02e-07 | 200 | 211 | 9 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-07 | 200 | 211 | 9 | 2a9d715aba8bdef2341b0d44ff60825c074a4b03 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.14e-06 | 163 | 211 | 8 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-06 | 168 | 211 | 8 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-06 | 168 | 211 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-06 | 169 | 211 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 170 | 211 | 8 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 119 | 211 | 7 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-06 | 172 | 211 | 8 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-06 | 175 | 211 | 8 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 176 | 211 | 8 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-06 | 176 | 211 | 8 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-06 | 176 | 211 | 8 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 180 | 211 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 180 | 211 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-06 | 181 | 211 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-06 | 181 | 211 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.71e-06 | 183 | 211 | 8 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-06 | 183 | 211 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-06 | 183 | 211 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-06 | 183 | 211 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-06 | 183 | 211 | 8 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-06 | 184 | 211 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-06 | 184 | 211 | 8 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.82e-06 | 184 | 211 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-06 | 184 | 211 | 8 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-06 | 184 | 211 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 185 | 211 | 8 | e1fbec55b71f604189eb2431768fadbaa0453a83 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 185 | 211 | 8 | 9d933cd5ebc8368fd37aa83113d2dfa6938ff72d | |
| ToppCell | COPD-Epithelial-ATI|COPD / Disease state, Lineage and Cell class | 3.06e-06 | 186 | 211 | 8 | df0977f6f48a2d4e11b59971f098b01204242f0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 186 | 211 | 8 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-06 | 187 | 211 | 8 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-06 | 187 | 211 | 8 | 380c3e0bc73b266718893a3b3ca207ce5fd31883 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 187 | 211 | 8 | 5b3c3c6421efd25c740ae121968b5520bbdc07b2 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-06 | 187 | 211 | 8 | 796046ff066a9c3847faa9bf1f8beccd956c01f7 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 3.44e-06 | 189 | 211 | 8 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 211 | 8 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 211 | 8 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.44e-06 | 189 | 211 | 8 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 211 | 8 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | droplet-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-06 | 190 | 211 | 8 | 0114cf48612d78c3ada4d8a05850501fef6892c5 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-06 | 190 | 211 | 8 | 01e7747547ea1f3049a11a1717565ba71dd52bdc | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 190 | 211 | 8 | e647f9a2dcf7f2dffef53c45bbe171416518fd59 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-06 | 190 | 211 | 8 | 434de72dde09644efbddcaa643a4a3eaf5f643bf | |
| Computational | Adhesion molecules. | ITGAM PTPRF COL6A3 COL7A1 COL12A1 FN1 DSG2 TNC ICAM1 CDH5 TNXB CDH17 | 8.80e-08 | 141 | 126 | 12 | MODULE_122 |
| Drug | Epothilone D | 4.78e-08 | 12 | 210 | 5 | DB01873 | |
| Drug | Epothilone B | 4.78e-08 | 12 | 210 | 5 | DB03010 | |
| Drug | Azacitidine | PCDHA9 NLGN3 PCDH18 FAM8A1 COL6A3 RANBP2 TNC PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 RET TERT | 3.42e-07 | 415 | 210 | 17 | ctd:D001374 |
| Drug | cyclofenil | 3.48e-07 | 31 | 210 | 6 | CID000002898 | |
| Drug | 2-aminothiophenol | 7.74e-07 | 3 | 210 | 3 | ctd:C005464 | |
| Drug | DTAF | 1.05e-06 | 37 | 210 | 6 | CID000123934 | |
| Drug | AC1L1KMJ | TUBA3E TUBA8 ITGAM TUBA1A PKD1 COL6A3 COL7A1 COL12A1 FN1 TUBA1C ICAM1 FNDC3A CRK SLC12A2 ROCK1 PRKCE CDH5 | 2.25e-06 | 476 | 210 | 17 | CID000030956 |
| Drug | AC1Q6P06 | 2.91e-06 | 25 | 210 | 5 | CID000160263 | |
| Drug | 3-ethylpyridine | 3.07e-06 | 4 | 210 | 3 | CID000010823 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 3.07e-06 | 4 | 210 | 3 | DB07574 | |
| Drug | DMSe | 3.88e-06 | 132 | 210 | 9 | CID000020796 | |
| Drug | Penicillamine | 8.97e-06 | 111 | 210 | 8 | ctd:D010396 | |
| Drug | vinorelbine base | 9.23e-06 | 80 | 210 | 7 | CID000005672 | |
| Drug | 2-demethylcolchicine | 1.05e-05 | 32 | 210 | 5 | CID000023757 | |
| Drug | B-Ms | 1.09e-05 | 114 | 210 | 8 | CID000445091 | |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.36e-05 | 194 | 210 | 10 | 2377_UP | |
| Drug | Rgd Peptide | DPP8 ITGAM COL6A3 COL12A1 FN1 TNC ICAM1 FNDC3A DPP9 TNR TNXB | 1.46e-05 | 239 | 210 | 11 | CID000104802 |
| Drug | AC1O5SNJ | 1.52e-05 | 6 | 210 | 3 | CID006439900 | |
| Drug | pregnanetriol | 1.90e-05 | 36 | 210 | 5 | CID000101967 | |
| Drug | A-FN | 2.45e-05 | 19 | 210 | 4 | CID005287635 | |
| Drug | 21-deoxycortisol | 2.84e-05 | 39 | 210 | 5 | CID000092827 | |
| Drug | pyrazolo(3,4-d)pyrimidine | 3.49e-05 | 98 | 210 | 7 | ctd:C014175 | |
| Drug | bromocolchicine | 3.72e-05 | 21 | 210 | 4 | CID000161518 | |
| Drug | colchifoline | 3.72e-05 | 21 | 210 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 3.72e-05 | 21 | 210 | 4 | CID000164454 | |
| Drug | SRI-3072 | 3.72e-05 | 21 | 210 | 4 | CID000493469 | |
| Drug | vindesine | 3.90e-05 | 68 | 210 | 6 | CID000040839 | |
| Drug | Paclitaxel | ATP7A ITGAM C1S C4A KIT HSPA1L IL17RB COL6A3 COL7A1 FRAS1 FN1 TNC ICAM1 MUC16 TERT SLC12A2 ROCK1 PRKCE BUB3 | 4.16e-05 | 720 | 210 | 19 | ctd:D017239 |
| Drug | Te-U | 4.19e-05 | 8 | 210 | 3 | CID000014465 | |
| Drug | 3,4,5-trimethoxyacetophenone | 4.52e-05 | 22 | 210 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 4.52e-05 | 22 | 210 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 4.52e-05 | 22 | 210 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 4.52e-05 | 22 | 210 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 4.52e-05 | 22 | 210 | 4 | CID000023759 | |
| Drug | NSC-339672 | 4.52e-05 | 22 | 210 | 4 | CID000433930 | |
| Drug | LMWH | NRG1 KCNB2 ITGAM KCNA5 PCYT2 C1S C4A NID2 COL6A3 COL7A1 COL12A1 FN1 TNC FNDC3A POLR3B TNR TNXB EPHA4 | 4.63e-05 | 663 | 210 | 18 | CID000000772 |
| Drug | ABT-751 | 5.16e-05 | 44 | 210 | 5 | CID003035714 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 5.43e-05 | 23 | 210 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 5.43e-05 | 23 | 210 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 5.43e-05 | 23 | 210 | 4 | CID000125548 | |
| Drug | NSC-373301 | 5.43e-05 | 23 | 210 | 4 | CID000341375 | |
| Drug | NSC355636 | 5.43e-05 | 23 | 210 | 4 | CID000100176 | |
| Drug | IKP104 | 5.43e-05 | 23 | 210 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 5.43e-05 | 23 | 210 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 5.43e-05 | 23 | 210 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 5.43e-05 | 23 | 210 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 5.43e-05 | 23 | 210 | 4 | CID000097865 | |
| Drug | Ibuprofen | GBE1 ITGAM FASN PCYT2 NOS1 IL17RB BAHCC1 CORO2A TNC PCLO ICAM1 DPP9 SEC24C ABCE1 | 5.89e-05 | 437 | 210 | 14 | ctd:D007052 |
| Drug | colchine | TUBA3E TUBA8 TUBA1A PKD1 NOS1 COL6A3 COL7A1 COL12A1 FN1 TNC TUBA1C ICAM1 FNDC3A | 6.07e-05 | 383 | 210 | 13 | CID000002833 |
| Drug | bumadizone | 6.24e-05 | 9 | 210 | 3 | CID000019161 | |
| Drug | parbendazole | 6.47e-05 | 24 | 210 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 6.47e-05 | 24 | 210 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 6.47e-05 | 24 | 210 | 4 | CID000330401 | |
| Drug | NABV | 6.47e-05 | 24 | 210 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 6.47e-05 | 24 | 210 | 4 | CID000163705 | |
| Drug | moscatilin | 6.47e-05 | 24 | 210 | 4 | CID000176096 | |
| Drug | NSC-36768 | 6.47e-05 | 24 | 210 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 6.47e-05 | 24 | 210 | 4 | CID000014995 | |
| Drug | colchicide | 6.47e-05 | 24 | 210 | 4 | CID000120712 | |
| Drug | aspartyl-phenylalanine | 6.52e-05 | 108 | 210 | 7 | CID000541493 | |
| Drug | mpMap | 7.64e-05 | 25 | 210 | 4 | CID000100806 | |
| Drug | allocolchicine | 7.64e-05 | 25 | 210 | 4 | CID000196989 | |
| Drug | 1069C85 | 7.64e-05 | 25 | 210 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 7.64e-05 | 25 | 210 | 4 | CID006438440 | |
| Drug | MDL 27048 | 7.64e-05 | 25 | 210 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 7.64e-05 | 25 | 210 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 7.64e-05 | 25 | 210 | 4 | CID000043264 | |
| Drug | CA1P | 7.64e-05 | 25 | 210 | 4 | CID006918545 | |
| Drug | peloruside A | 7.64e-05 | 25 | 210 | 4 | CID006918506 | |
| Drug | NSC142227 | 7.64e-05 | 25 | 210 | 4 | CID000073427 | |
| Drug | UAMC00132 | 8.47e-05 | 2 | 210 | 2 | ctd:C524159 | |
| Drug | calcium hydride | 8.47e-05 | 2 | 210 | 2 | CID000105052 | |
| Drug | NSC527981 | 8.97e-05 | 26 | 210 | 4 | CID000352796 | |
| Drug | NSC332029 | 8.97e-05 | 26 | 210 | 4 | CID000100073 | |
| Drug | indibulin | 8.97e-05 | 26 | 210 | 4 | CID000002929 | |
| Drug | pironetin | 8.97e-05 | 26 | 210 | 4 | CID006438891 | |
| Drug | isaxonine | 8.97e-05 | 26 | 210 | 4 | CID000071169 | |
| Drug | epo906 | 9.18e-05 | 114 | 210 | 7 | CID000388945 | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; PC3; HT_HG-U133A | 9.34e-05 | 197 | 210 | 9 | 4249_UP | |
| Drug | indole alkaloid | TUBA3E TUBA8 TUBA1A PCYT2 PLXNA1 NTF3 TUBA1C TERT TRAP1 PRKCE | 9.47e-05 | 244 | 210 | 10 | CID000005978 |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; HL60; HT_HG-U133A | 9.71e-05 | 198 | 210 | 9 | 1859_UP | |
| Drug | AC1L1J4H | 1.05e-04 | 27 | 210 | 4 | CID000004862 | |
| Drug | dinitroanilines | 1.05e-04 | 27 | 210 | 4 | CID000136400 | |
| Drug | NSC292222 | 1.05e-04 | 27 | 210 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 1.05e-04 | 27 | 210 | 4 | CID000178028 | |
| Drug | AC1L1KAE | 1.06e-04 | 51 | 210 | 5 | CID000005407 | |
| Drug | TK-B | 1.06e-04 | 51 | 210 | 5 | CID000009074 | |
| Drug | ss,ss-carotene | 1.09e-04 | 201 | 210 | 9 | CID000000573 | |
| Drug | Rotenone | ATR RPS3 TUBA8 ITGAM TUBA1B FASN PTPRD KCNA5 TUBA1A NPC1L1 COL6A3 REXO4 FN1 TUBA1C ICAM1 RET TRAP1 TNN PRKCE CTSB TNXB CDH15 | 1.09e-04 | 978 | 210 | 22 | ctd:D012402 |
| Drug | NSC 370147 | 1.21e-04 | 28 | 210 | 4 | CID000182762 | |
| Drug | NSC72302 | 1.21e-04 | 28 | 210 | 4 | CID000118078 | |
| Drug | bp U | 1.39e-04 | 29 | 210 | 4 | CID000368697 | |
| Drug | oxibendazole | 1.39e-04 | 29 | 210 | 4 | CID000004622 | |
| Drug | Aids106696 | 1.39e-04 | 29 | 210 | 4 | CID006475933 | |
| Drug | ddGDP | 1.39e-04 | 29 | 210 | 4 | CID000134739 | |
| Drug | AC1NBBHE | 1.60e-04 | 30 | 210 | 4 | CID004490620 | |
| Drug | eleutherobin | 1.60e-04 | 30 | 210 | 4 | CID006918335 | |
| Drug | azatoxin | 1.60e-04 | 30 | 210 | 4 | CID000125383 | |
| Drug | NSC617668 | 1.60e-04 | 30 | 210 | 4 | CID000357989 | |
| Drug | citostal | 1.60e-04 | 30 | 210 | 4 | CID000018991 | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.40e-15 | 29 | 203 | 10 | EFO_0008009 |
| Disease | microlissencephaly (implicated_via_orthology) | 5.23e-15 | 8 | 203 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 5.23e-15 | 8 | 203 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 5.23e-15 | 8 | 203 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 8.67e-12 | 27 | 203 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | neutrophil count, basophil count | PCDHA9 PTPRJ KIT PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TERT CRK TRAP1 | 5.24e-11 | 224 | 203 | 15 | EFO_0004833, EFO_0005090 |
| Disease | post-traumatic stress disorder symptom measurement | PHF2 PTPRD SOX6 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.64e-10 | 82 | 203 | 10 | EFO_0008535 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.80e-10 | 87 | 203 | 10 | EFO_0004340, EFO_0004765 |
| Disease | post-traumatic stress disorder | KCNB2 HSPA13 NOS1 SOX6 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.72e-07 | 202 | 203 | 11 | EFO_0001358 |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 GBE1 NOS1 PCLO PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PTPRU GTF3C1 TNR | 2.18e-06 | 566 | 203 | 16 | EFO_0007660, EFO_0008354 |
| Disease | pulse pressure measurement | NRG1 PCDHA9 NEK9 ABHD17C FASN PTPRD PKD1 NADK QSOX2 SOX6 FLNB COL6A3 FN1 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 CRK SLC12A2 PRKCE CDH17 | 3.87e-06 | 1392 | 203 | 26 | EFO_0005763 |
| Disease | vital capacity | NRG1 PCDHA9 PTPRD NADK MICAL3 QSOX2 PLXNA1 SOX6 COL6A3 FN1 PCLO PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SIM2 PARD3 TNS1 TNXB | 4.93e-06 | 1236 | 203 | 24 | EFO_0004312 |
| Disease | depressive symptom measurement | PHF2 HERC1 NOS1 SOX6 PCLO PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 VPS41 TNXB EPHA7 | 8.94e-06 | 426 | 203 | 13 | EFO_0007006 |
| Disease | Lupus Erythematosus, Systemic | 9.72e-06 | 71 | 203 | 6 | C0024141 | |
| Disease | neutrophil count | MAGI1 PCDHA9 CYP21A2 DPP8 F11R PTPRJ PKD1 GNA15 KIT FLNB PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 TERT CRK TRAP1 GTF3C1 TNR TNXB | 1.04e-05 | 1382 | 203 | 25 | EFO_0004833 |
| Disease | unipolar depression | NRG1 AKR1E2 FASN PTPRD GRHPR PKD1 ALPK3 KLHDC7A NOS1 SOX6 SELENBP1 TNC PCLO PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SHANK2 VPS41 PARD3 TNR EPHA7 | 1.05e-05 | 1206 | 203 | 23 | EFO_0003761 |
| Disease | melanoma | 5.93e-05 | 248 | 203 | 9 | C0025202 | |
| Disease | Abnormality of refraction | SMG1 PCDHA9 PTPRF QSOX2 PCLO PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PARD3 | 7.17e-05 | 673 | 203 | 15 | HP_0000539 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.32e-04 | 71 | 203 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | Colorectal Neoplasms | 1.38e-04 | 277 | 203 | 9 | C0009404 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.41e-04 | 3 | 203 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.41e-04 | 3 | 203 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Disease Exacerbation | 1.53e-04 | 165 | 203 | 7 | C0235874 | |
| Disease | autistic disorder (is_implicated_in) | 1.98e-04 | 42 | 203 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 2.03e-04 | 17 | 203 | 3 | C1839839 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 2.80e-04 | 4 | 203 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 2.80e-04 | 4 | 203 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 2.80e-04 | 4 | 203 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 2.80e-04 | 4 | 203 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 2.80e-04 | 4 | 203 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 2.80e-04 | 4 | 203 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | severe acute respiratory syndrome, COVID-19 | MAGI1 ZFYVE1 BBS9 PTPRD ARNT2 DHRSX COL6A3 PCDHA6 PARD3 TNR EPHA7 | 2.91e-04 | 447 | 203 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Colorectal Carcinoma | KCNB2 CDKL5 PTPRD FLNC COL7A1 FN1 SELENBP1 RET PTPRU ABCE1 PRKCE CDH5 DCLK1 EPHA7 | 3.87e-04 | 702 | 203 | 14 | C0009402 |
| Disease | Tourette syndrome | 3.91e-04 | 50 | 203 | 4 | EFO_0004895 | |
| Disease | cortical surface area measurement | MAGI1 DCHS2 SLC9A9 CYP21A2 BBS9 KCNA5 PTPRF TUBA1A PKD1 KIT PITPNM2 FLNB IFT22 TUBA1C ACKR4 PARD3 TNS1 TNXB DCLK1 EPHA4 EPHA7 | 4.16e-04 | 1345 | 203 | 21 | EFO_0010736 |
| Disease | complement C4 measurement | 4.55e-04 | 52 | 203 | 4 | EFO_0004984 | |
| Disease | Hypoplastic Left Heart Syndrome | 4.65e-04 | 5 | 203 | 2 | C0152101 | |
| Disease | muscular disease (implicated_via_orthology) | 4.65e-04 | 5 | 203 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | body weight | NRG1 CYP21A2 KCNB2 ZFYVE1 APOBR ABHD17C FASN PTPRJ PKD1 NADK MGA KIT PLXNA1 NID2 EXOSC9 PCDHA1 RET SLC12A2 PRKCE EPHA4 | 4.70e-04 | 1261 | 203 | 20 | EFO_0004338 |
| Disease | Bipolar Disorder | MAGI1 NRG1 TUBA8 ITGAM PCLO TOM1 SHANK2 SEC24C ASMT DCLK1 CDH17 | 5.01e-04 | 477 | 203 | 11 | C0005586 |
| Disease | Metastatic melanoma | 5.26e-04 | 54 | 203 | 4 | C0278883 | |
| Disease | coronary artery disease | TMEM165 CNPY2 KCNB2 NEK9 PHF2 PTPRJ C1S PCDH18 SOX6 COL6A3 FAT4 FN1 CDKN2AIP PTPRU ACTR2 PRKCE TNS1 TNXB CDH17 | 6.27e-04 | 1194 | 203 | 19 | EFO_0001645 |
| Disease | leiomyosarcoma (is_marker_for) | 6.94e-04 | 6 | 203 | 2 | DOID:1967 (is_marker_for) | |
| Disease | diabetic angiopathy (implicated_via_orthology) | 6.94e-04 | 6 | 203 | 2 | DOID:11713 (implicated_via_orthology) | |
| Disease | clubfoot (implicated_via_orthology) | 6.94e-04 | 6 | 203 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | brain ischemia (biomarker_via_orthology) | 7.12e-04 | 102 | 203 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 8.88e-04 | 62 | 203 | 4 | DOID:9074 (is_implicated_in) | |
| Disease | lysophosphatidylcholine measurement | 8.88e-04 | 62 | 203 | 4 | EFO_0010224 | |
| Disease | reticulocyte count | ATR CNOT8 PTPRJ PKD1 RNF10 NADK C4B HERC1 SOX6 PITPNM2 FLNB OR10X1 CRK SV2C PRKCE TNS1 CDH5 | 9.55e-04 | 1045 | 203 | 17 | EFO_0007986 |
| Disease | Early Pregnancy Loss | 9.60e-04 | 109 | 203 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 9.60e-04 | 109 | 203 | 5 | C0000786 | |
| Disease | Miscarriage | 9.60e-04 | 109 | 203 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 9.60e-04 | 109 | 203 | 5 | C0000822 | |
| Disease | pulmonary hypertension (is_marker_for) | 1.00e-03 | 64 | 203 | 4 | DOID:6432 (is_marker_for) | |
| Disease | Stomach Neoplasms | 1.10e-03 | 297 | 203 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.17e-03 | 300 | 203 | 8 | C0024623 | |
| Disease | chronic kidney disease | 1.26e-03 | 235 | 203 | 7 | EFO_0003884 | |
| Disease | cardiovascular measurement, left ventricular function | 1.28e-03 | 8 | 203 | 2 | EFO_0004295, EFO_0004298 | |
| Disease | Unilateral agenesis of kidney | 1.28e-03 | 8 | 203 | 2 | C0266294 | |
| Disease | X-17676 measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0800785 | |
| Disease | Breast Carcinoma | NRG1 INPP4B FASN PTPRD KLHDC7A KIT COL7A1 FN1 AGR2 TERT CDH5 | 1.33e-03 | 538 | 203 | 11 | C0678222 |
| Disease | pulmonary sarcoidosis (is_marker_for) | 1.37e-03 | 32 | 203 | 3 | DOID:13406 (is_marker_for) | |
| Disease | melanoma (is_marker_for) | 1.50e-03 | 33 | 203 | 3 | DOID:1909 (is_marker_for) | |
| Disease | Complement deficiency disease | 1.50e-03 | 33 | 203 | 3 | C0272242 | |
| Disease | glioblastoma multiforme | 1.64e-03 | 9 | 203 | 2 | EFO_0000519 | |
| Disease | Behcet's disease (is_implicated_in) | 1.94e-03 | 36 | 203 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | multiple myeloma (is_marker_for) | 1.94e-03 | 36 | 203 | 3 | DOID:9538 (is_marker_for) | |
| Disease | Malignant Neoplasms | 1.96e-03 | 128 | 203 | 5 | C0006826 | |
| Disease | hypertension (implicated_via_orthology) | 1.96e-03 | 128 | 203 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0022035 | |
| Disease | pleural tuberculosis (is_marker_for) | 2.04e-03 | 10 | 203 | 2 | DOID:106 (is_marker_for) | |
| Disease | tenascin measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0008296 | |
| Disease | dry eye syndrome (is_marker_for) | 2.04e-03 | 10 | 203 | 2 | DOID:10140 (is_marker_for) | |
| Disease | ovarian neoplasm | 2.39e-03 | 134 | 203 | 5 | C0919267 | |
| Disease | diffuse plaque measurement | NRG1 DCHS2 RPS3 TMEM132B HSPA13 PHF2 AKR1E2 PTPRD COL6A3 TERT SHANK2 TNS1 EPHA7 | 2.40e-03 | 758 | 203 | 13 | EFO_0010699 |
| Disease | Graves' disease (is_implicated_in) | 2.44e-03 | 39 | 203 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | human immunodeficiency virus infectious disease (is_implicated_in) | 2.44e-03 | 39 | 203 | 3 | DOID:526 (is_implicated_in) | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 2.49e-03 | 11 | 203 | 2 | EFO_0009923 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 2.49e-03 | 11 | 203 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | microfibrillar-associated protein 2 measurement | 2.49e-03 | 11 | 203 | 2 | EFO_0801801 | |
| Disease | visual epilepsy (is_implicated_in) | 2.49e-03 | 11 | 203 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Malignant neoplasm of ovary | 2.63e-03 | 137 | 203 | 5 | C1140680 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 2.97e-03 | 12 | 203 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.97e-03 | 12 | 203 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Kawasaki disease (is_implicated_in) | 2.97e-03 | 12 | 203 | 2 | DOID:13378 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NRG1 INPP4B FASN PTPRD KCNA5 KLHDC7A KIT NID2 FLNB COL7A1 FN1 AGR2 TECTA TERT TNS1 CDH5 | 3.23e-03 | 1074 | 203 | 16 | C0006142 |
| Disease | Schizophrenia | MAGI1 NRG1 ITGAM CCR5 NLGN2 HSPA1L NOS1 SELENBP1 NTF3 ICAM1 ACTR2 SLC12A2 TNXB DCLK1 | 3.35e-03 | 883 | 203 | 14 | C0036341 |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 3.49e-03 | 13 | 203 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.56e-03 | 147 | 203 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 3.62e-03 | 525 | 203 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.62e-03 | 525 | 203 | 10 | C1257931 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.68e-03 | 45 | 203 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Mammary Neoplasms | 3.71e-03 | 527 | 203 | 10 | C1458155 | |
| Disease | Malignant neoplasm of prostate | ATR PDHA1 GRHPR MGA ICAM1 AGR2 TERT APPL2 SLC12A2 PARD3 CTSB | 3.77e-03 | 616 | 203 | 11 | C0376358 |
| Disease | Prostatic Neoplasms | ATR PDHA1 GRHPR MGA ICAM1 AGR2 TERT APPL2 SLC12A2 PARD3 CTSB | 3.77e-03 | 616 | 203 | 11 | C0033578 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 4.06e-03 | 14 | 203 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Hamman-Rich syndrome | 4.06e-03 | 14 | 203 | 2 | C0085786 | |
| Disease | unipolar depression, anxiety | 4.06e-03 | 14 | 203 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.10e-03 | 152 | 203 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | end stage renal disease (biomarker_via_orthology) | 4.16e-03 | 47 | 203 | 3 | DOID:783 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLSGPEEAGSVRRYT | 236 | B0FP48 | |
| EGASESPYDRAVLIS | 61 | Q9UK28 | |
| VDPSLTVRADITGRY | 131 | O95994 | |
| TYDPTTGRLVTADGV | 2621 | Q9P281 | |
| RPSGTEDVVRVYAEA | 496 | O95394 | |
| IESEVVAGIPRTDQY | 321 | P07858 | |
| SYVRVTASDPLDTLG | 976 | P0C0L5 | |
| ENISYGIEPVESSAR | 121 | Q9Y3Q7 | |
| PLGYTVTRVTTSDED | 2786 | Q6V0I7 | |
| FVDLTLPYSVVRGES | 791 | A8K2U0 | |
| VIDREGVYEISLSPT | 71 | Q96Q83 | |
| GVYEISLSPTGVSRV | 76 | Q96Q83 | |
| PSSETSLVGRNYDVT | 1656 | Q96L96 | |
| LSSIEGRVAVEYLDP | 196 | O43684 | |
| NSSSYRIGPVEVESA | 476 | Q6NUN0 | |
| GVPAEELFTAIYRSE | 136 | P46597 | |
| DPETRSAVELTLIGY | 371 | A6NFU0 | |
| APERASSVYTRSTGE | 331 | P51681 | |
| TKYTFVVPEDTRVGT | 261 | P33151 | |
| ETTVLVESYTLPDGR | 236 | P61160 | |
| YREEFPQIEGSALTT | 91 | Q96DT6 | |
| ETGRVIYVSDSVTPV | 156 | Q9HBZ2 | |
| EAVSPGLYRVSITSE | 336 | Q04656 | |
| LVRDSSTSPGDYVLS | 36 | P46108 | |
| ADVERYIASVQGSTP | 6 | P49792 | |
| YELVVTARDGGSPSL | 421 | Q9Y5H5 | |
| AGSEAVRYSIPEETE | 26 | Q9Y5E4 | |
| RVTYTRVSPGQAEDV | 51 | Q8NBR0 | |
| IPYESIVVTRALDGD | 231 | Q6ZRP7 | |
| IRYSVPEETDKGSFV | 31 | Q9Y5G5 | |
| ASTEGAYVSSESPIR | 141 | Q02297 | |
| YSLTVIAEDRGTPSL | 431 | Q9HCL0 | |
| YELVVTARDGGSPSL | 421 | Q9Y5H9 | |
| YELVVTARDGGSPSL | 421 | Q9UN73 | |
| DRYVAVTKVPSQSGV | 136 | Q9NPB9 | |
| LEAYLTTGEAETRVP | 201 | O00763 | |
| IIDLAGDTVRYTPAS | 321 | O75808 | |
| AISEDYPRKTITGTV | 471 | Q14126 | |
| YELVVTARDGGSPSL | 421 | Q9UN72 | |
| ATESESRGAIYSIPI | 396 | Q96GW7 | |
| LTEVYPELGTQGRSS | 1586 | Q8WXI7 | |
| AGAAEPRSYSVVEET | 26 | Q9Y5F0 | |
| DATVTELIPGSSYTV | 681 | Q12913 | |
| SGDDTLIAVPYTVIT | 281 | Q8NGY0 | |
| YELVVTARDGGSPSL | 421 | Q9Y5H6 | |
| YELVVTARDGGSPSL | 421 | Q9Y5H8 | |
| GTSPLEVLAERESIY | 431 | Q7RTP6 | |
| TDQDSGPTELIYRIT | 2226 | Q86XX4 | |
| STVVQPYDVEIRRGE | 991 | Q96QZ7 | |
| EAPIAVVTSRTSEVY | 336 | Q8TD19 | |
| SISGDRQPVTVADYI | 601 | P51116 | |
| GKPRTYITEERADVS | 1006 | Q8IWI9 | |
| SVRIGSYIERDVTPA | 741 | P10721 | |
| VSVAVTPDGYADAVR | 81 | P0C870 | |
| PEGRVYVIIDLSGSS | 121 | Q02156 | |
| VYDDGATALPATRVV | 496 | Q9P244 | |
| TRYSSTEIVEGTRDP | 76 | O15327 | |
| RGELETLGTTYPAET | 4081 | Q2LD37 | |
| RVSTDLPEGQDVYTA | 1426 | Q15751 | |
| EPVTTSVATGDYSIL | 51 | Q9NRM6 | |
| GIKVTDAPTYTTRDE | 106 | Q9NXV6 | |
| SEEGFQIPATITERY | 376 | O15075 | |
| TGSRVYPANEVTLLD | 21 | P54764 | |
| SSISGYDIPEGTVII | 371 | P08686 | |
| RRPDVSVQGDEVTLY | 161 | Q06265 | |
| IVDNKDGTVTVRYAP | 1776 | O75369 | |
| DGTVTVRYAPTEVGL | 1781 | O75369 | |
| VVIDRGPSSYLSNVD | 286 | O95544 | |
| YPETRQVISGAGIST | 3046 | Q9Y6V0 | |
| VSEVVIGAPYAVTAE | 281 | Q99447 | |
| PIDAITGEARYSLSE | 1476 | Q9UIW2 | |
| PIDAITGEARYSLSE | 1451 | P51805 | |
| DRGSVPLSSVTEVYI | 1111 | Q9NYQ8 | |
| SEYNITVTATDRGTP | 416 | Q9Y5G4 | |
| LRYSVVEESEPGTLV | 31 | Q9Y5F6 | |
| DNKDGTITVRYAPTE | 1816 | Q14315 | |
| IVEGEDSAYSVRFVP | 2266 | Q14315 | |
| AYPEVLAQGRTARVT | 141 | Q8N2G8 | |
| PSYVAFTDTERLIGD | 41 | P34931 | |
| VGATGVITDYPTALR | 291 | Q7L5L3 | |
| TEEGYVPTAQDVLRS | 171 | P30679 | |
| VSYTIPESHRLGVGV | 1066 | Q9BZ72 | |
| EDYVGSPVVANRTSR | 121 | P20783 | |
| EEISGLDENYTPIRT | 56 | Q15375 | |
| YSPRLDVATLEEATG | 526 | Q15375 | |
| RVIEDDPEAVYTTTG | 781 | Q15375 | |
| TPSELEGNAVVSYSR | 496 | Q3SYG4 | |
| TVAIVSYRTRDGEGP | 1196 | P29475 | |
| VDVSNVVPGTRYDIT | 61 | Q9UMZ3 | |
| EAGYIDSTIVRTPES | 331 | Q9UMZ3 | |
| TEYEISVLLTRPGDG | 351 | Q92729 | |
| VSEGARPGDYVARVS | 426 | Q6V1P9 | |
| YELVVTARDGGSPSL | 421 | Q9Y5I3 | |
| YELVVTARDGGSPSL | 421 | Q9Y5I0 | |
| EYGPTESVKVIRDAS | 221 | Q96DU9 | |
| YPGEETVRITQTAEG | 621 | Q14112 | |
| DTVAILSPRLEYSGT | 1046 | Q9UHC9 | |
| YELVVTARDGGSPSL | 421 | Q9UN74 | |
| PRDYSTELSVTIAVG | 701 | Q9NZ94 | |
| AIIPGSVYDRSSQGR | 951 | Q92900 | |
| TYLADRVIVFDGVPS | 526 | P61221 | |
| RELGSATPEEYNTVV | 16 | Q13535 | |
| SRYGTPEELQELVDT | 261 | Q04446 | |
| SSDITEYSPTQGVRI | 26 | Q9H7X7 | |
| AEVRPSLEVGYLTSA | 1141 | Q9Y2F5 | |
| EYPESSGSARAIAIV | 241 | P22460 | |
| AARDGTLEYAPVDIT | 661 | Q92953 | |
| IYRPVAGGESREVTT | 756 | Q99715 | |
| DTTPAKTIVVYRNGD | 11 | A8MYV0 | |
| SYEAAGEIVRLTTPG | 531 | Q86TI2 | |
| LVERSTLGSATIPYE | 321 | Q8NCQ5 | |
| ESAVTGYRVDVIPVN | 931 | P02751 | |
| VTEATITGLEPGTEY | 2046 | P02751 | |
| PETSKLERSGTVIAY | 76 | Q5SR53 | |
| VPLSNGTDVTEYRLE | 781 | Q9Y2H6 | |
| LVVITSGDPRYDVAD | 1111 | A8TX70 | |
| SYVNPGEVTRLTDRG | 556 | Q6V1X1 | |
| DGSQSVVEVPYARSE | 61 | Q9Y2B0 | |
| VLISAGPSSDEIRYG | 351 | P12111 | |
| LTTYVSGGVEEVPLA | 816 | P12111 | |
| VIDPRAGTVLQEASY | 206 | Q92828 | |
| RGIRVGYTPDVLTDT | 96 | Q9UBQ7 | |
| SREVIVVDLGNEYPT | 161 | A8MZ97 | |
| EDPESTLFGSVIRYT | 371 | P09871 | |
| TSIYAAVTPELEGVG | 276 | Q8N5I4 | |
| SIGTVPTVDLASRYE | 211 | Q6PCB6 | |
| RVPESTGEESLSTYI | 581 | Q8NEU8 | |
| VELSEDISETGYVRP | 896 | Q9Y5Q5 | |
| IRTVEEGAETPVYLA | 241 | O75828 | |
| RGPYVLVTGATSTDR | 101 | Q5VTJ3 | |
| VVVRPIGEFRSSIDY | 46 | Q9UFF9 | |
| SSQRVTGLEPGVSYI | 1011 | Q02388 | |
| SNETITVSPEYVGSR | 136 | P48723 | |
| ERDRPYGLVSIDTVT | 366 | Q9HBE5 | |
| IGESVTVTRDLEGTY | 441 | P05362 | |
| PTQIESLAEGIARYS | 2476 | Q8NDH2 | |
| TSEALSRDPETLVGY | 116 | P49327 | |
| DREAGSPYRVQVVAT | 626 | Q12864 | |
| SPYRVQVVATEVGGS | 631 | Q12864 | |
| VTRSATEGPSYSEQL | 916 | O76039 | |
| VLQPGAEVTTDDRAY | 916 | P53992 | |
| ERGYSPKDVAVLVST | 801 | Q68D06 | |
| VPGTYVTRAEATDAD | 166 | P55291 | |
| PGDSRDYSTELSVTV | 666 | Q8NFZ4 | |
| GTYRPSSEEQVGARV | 91 | Q9BUF7 | |
| SYVRVTASDPLDTLG | 976 | P0C0L4 | |
| SETGRQAGREYVIPS | 231 | Q9UBU6 | |
| LDVDAGPSTNRTVYT | 36 | O95954 | |
| RGAVTPEYTVANVIS | 51 | Q53RY4 | |
| DSLVILSGRDVTYTP | 2016 | P98161 | |
| RVILTSIDGVPGSDY | 1391 | P10586 | |
| YELVVTARDGGSPSL | 421 | Q9UN75 | |
| TSRDVTIGGSAPIYV | 476 | Q8TEW0 | |
| TEYRITVTAHTDVGP | 681 | P23468 | |
| AGAAEPRSYSVVEET | 26 | Q9UN66 | |
| ASYEDRVTFLPTGIT | 81 | Q9Y624 | |
| VTDYRTAVSGIRPEN | 286 | Q9GZR2 | |
| DTDRLPEFIVQTGSY | 36 | A6ZKI3 | |
| PQILVDRGSETTYES | 31 | Q5H9L4 | |
| SLSGPEEAGSVRRYT | 236 | E5RIL1 | |
| VVTVELYPTDRRATG | 656 | Q496J9 | |
| GSTVEVRVSYVENPG | 771 | O60522 | |
| NYVGPERSVDVTDVT | 151 | O75151 | |
| LRYATAPTDIESGTV | 66 | Q8IVB4 | |
| DGSYLLRDSESVPGV | 26 | O60880 | |
| RERIGSVVVYPTQDD | 256 | Q14DG7 | |
| EASIVGENETYPRAL | 601 | Q9UBV2 | |
| YTEEPRVKTVSDVGA | 641 | Q8NE09 | |
| YPRIESESTVHIGVG | 1581 | Q96Q15 | |
| GVTSELPETEYSLRA | 256 | Q8TE76 | |
| EVVYVEGRRSVTGVP | 126 | Q5JR12 | |
| DSRVTEVTGYEPQDL | 246 | Q14190 | |
| DRGYSPKDVAVLVST | 801 | Q7Z7L1 | |
| EDGYSGVEVRVTPTR | 31 | P23396 | |
| PTAEDTYRVSLAKGV | 46 | Q9C0D5 | |
| SSRIYVVDVGSEPRA | 101 | Q13228 | |
| QSVVTYDLALDSGRP | 671 | P11215 | |
| IVSEAGASIYSVSPE | 626 | Q8N5C6 | |
| ETIYDTIRATAEKPG | 31 | Q9UPX8 | |
| PTGGATVAEARVYRD | 596 | P35712 | |
| PAVSETTERTVLGEY | 1011 | Q9UK61 | |
| IGTVPSVDLAARYES | 171 | Q5VST6 | |
| QSRDVSVTAYRPLGG | 211 | Q96JD6 | |
| VSYLLGDAVPTVERE | 26 | Q0VD83 | |
| GDVVYADIKTVRTSP | 81 | Q8IZS7 | |
| DDYVTLRGKPVVSSV | 1631 | O75443 | |
| EPTVVDEVRTGTYRQ | 71 | P0DPH8 | |
| GTATYDLVSSTRLPE | 1236 | Q96KV7 | |
| SPGGVREALISDETY | 196 | Q96MH6 | |
| DPGVSYRTREEIQEV | 296 | P08559 | |
| VVRYTSAGGETREVP | 651 | Q9UQP3 | |
| RYTSAKDGETREVPV | 741 | Q9UQP3 | |
| STVLTGLRPGVEYTV | 761 | Q9UQP3 | |
| TTGTPARYEVRVDLQ | 1151 | Q9UQP3 | |
| SPDLTGVVTIYEDLR | 131 | O60784 | |
| YGSLERSPEKISATV | 531 | Q8N5U6 | |
| SVIPDSGYISEVRNF | 281 | Q9Y4K3 | |
| NGEESTPTRDAVVTY | 261 | P55011 | |
| VDPVYETLRFGTSLA | 196 | Q99469 | |
| VTVTAERGRAVSYPA | 906 | P22105 | |
| EPRSYVESVARTAVA | 1021 | Q9HBL0 | |
| EPTVVDEVRTGTYRQ | 71 | P0DPH7 | |
| YRTPVLSAEASTGET | 1151 | P24821 | |
| VQALRPGSRYEVSVS | 561 | Q92752 | |
| PGSRYEVSVSAVRGT | 566 | Q92752 | |
| APITVDIEYTRGSQR | 111 | Q9NW08 | |
| TTIVLAAREDPYGVA | 256 | Q9HC07 | |
| EGESLFYIVSPRDVV | 341 | P49754 | |
| YISRVVAVIGPDNSE | 131 | Q8TE23 | |
| ADVVPASGELVRRYT | 301 | P07949 | |
| VRPVTQGDVYRAETE | 1176 | Q13464 | |
| YERGEEVSVVPKTSA | 476 | Q9HBF4 | |
| VADRVEVYSRSAAPG | 211 | Q12931 | |
| KEEGPRYLSSTAVVV | 31 | Q9Y2D2 | |
| EPTVIDEVRTGTYRQ | 71 | Q71U36 | |
| FPGRSASYEDIIIDV | 2151 | Q5VWN6 | |
| EPTVVDEVRTGTYRQ | 71 | Q6PEY2 | |
| LYIPRDVDETGITVA | 336 | Q8WU90 | |
| YTTGSREVVDEGLIP | 1096 | Q12789 | |
| TYRSEVSSPIQRGDV | 561 | Q9HAU0 | |
| ETVISYESTPEVSRG | 1066 | Q9HAU0 | |
| EPTVIDEVRTGTYRQ | 71 | P68363 | |
| TQEPEILSFTYTGDR | 306 | O95125 | |
| EPTVIDEVRTGTYRQ | 71 | Q9BQE3 | |
| VDVTGAYDTIPQDRL | 711 | O14746 | |
| EPTVVDEVRAGTYRQ | 71 | Q9NY65 | |
| GLQSSVYESRRVTDP | 31 | Q9P2T0 | |
| AQGSYTTLPETRDTV | 5661 | P20929 | |
| QYPGIAVETVTDSSR | 76 | Q8NC96 |